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1.1 Bacterial Pathogenesis 
Microbial infection continues to be one of the major problems of human health 
today, therefore efforts in antimicrobial drug development have continued unabated.  One 
challenge of drug development is that some pathogenic bacterial strains mutate frequently 
to generate antimicrobial resistance, outdistancing drug discovery [1, 2]. The resistance 
may be generated under pressure of misuse of antibiotics or inappropriate operations in 
hospitals [3, 4]. The increase of resistance contributes to an incessant demand for new 
antibiotics [5]. 
Strategies combating microbial resistance include targeting the resistance 
mechanisms and finding new targets using genomics [6]. Genes that are essential for 
bacterial cell virulence or survival have long been drugable targets, and new candidates 
are under development. A classic example of a drugable target is the cell-wall 
biosynthetic pathway that produces the protective peptidoglycan layer. The 
transpeptidase in the pathway can be inhibited by the substrate-like β-lactam-containing 
molecules, thus preventing peptidoglycan from cross-linking to a protective wall in the 
bacteria [7]. However, these drugs are more effective against Gram-positive bacteria (G+) 
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than Gram-negative cells (G-), which differ from G+ by possessing an outer membrane 
outside the peptidoglycan wall [8]. Since many pathogenic G- strains cause more severe 
or even fatal diseases in human [9-11], antibiotics developed to specifically target the 
outer membrane biosynthesis are urgently needed.  
 
 
Figure 1-1 Gram-negative envelope [8] 
The asymmetric outer membrane of G- bacteria (Figure 1-1) consists of 
phospholipids on the inner leaflet and lipid A on the outer leaflet. Lipid A, 
polysaccharide core, and the outreaching O-antigen region constitute the 
lipopolysaccharide layer (LPS, also known as endotoxin). Lipid A is a phosphorylated N-
acetylglucosamine dimer connected by a β(1 6) linkage with 6 or 7 fatty acids attached 
[12]. It is responsible for the toxicity of LPS [13]. The polysaccharide chains are linked 
to lipid A through an eight carbon carbohydrate molecule, 3-deoxy-D-manno-
octulosonate (KDO). Two molecules of α(2 6)-linked KDO are required to incorporate 
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into LPS for proper E. coli cell growth (Figure 1-2) [14]. The number of KDO required 
in the LPS can vary from species to species. For instance, Bordetella pertussis [15] and 
Haemophilus influenzae [16] only incorporate one KDO molecule, while Chlamydia 
trachomatis [17] utilizes three KDO molecules as the linker between lipid A and 
polysaccharide. At the outreaching end of polysaccharide chains is a region termed O-
antigen which consists of repeating oligosaccharides and determines the antigenic 
specificity of bacterial strains [8]. Although the polysaccharide chain and O-antigen 
region adopt a wide range of carbohydrate molecules, KDO is universally present 
between lipid A and the polysaccharide chains. Failure to produce  KDO in bacterial cells 
may result in an accumulation of lipid A precursor and  cell growth arrest [18]. Cells 
interrupted in KDO biosynthesis are also less pathogenic and more labile to antibiotics 
[19, 20]. Since KDO is only found in the outer membrane of G- bacteria, pectins of 
higher plants [21-24] and cell walls of some green algae [25], it is a promising potential 



























Figure 1-2 KDO2-Lipid A 
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Four sequential enzymatic steps (Figure 1-3) are involved in the KDO 
biosynthetic pathway: 1) the isomerization of D-ribulose 5-phosphate (Ru5P) to form D-
arabinose 5-phosphate (A5P) by KdsD, 2) the condensation of A5P and 
phosphoenolpyruvate (PEP) to form 3-deoxy-D-manno-octulosonate 8-phosphate 
(KDO8P) by KdsA, 3) the hydrolysis of the phosphate ester KDO8P catalyzed by KdsC; 
and 4) the activation of KDO via addition of a CMP portion of CTP by KdsB. Finally the 
KDO moiety from the activated sugar nucleotide is transferred onto lipid A by a 
membrane-bound transferase, WaaA. These enzymes are all essential for E. coli cell 
survival (GenoBase, http://ecoli.aist-nara.ac.jp/). But in the cases where gene redundancy 
exists, for example, in E. coli where KdsD and GutQ share the same A5P isomerase 











































Figure 1-3. The KDO biosynthetic pathway. (1) KdsD: D-Arabinose 5-phosphate 
isomerase [EC: 5.3.1.31], (2) KdsA: KDO 8-phosphate synthase [EC: 2.5.1.55], (3) 
KdsC: KDO 8-phosphate phosphatase [EC: 3.1.3.45], (4) KdsB: KDO 





The 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase, KdsC [EC: 
3.1.3.45], is the third enzyme in the KDO biosynthetic pathway. This enzyme catalyzes 
the hydrolysis of KDO8P to form a molecule of KDO and an inorganic phosphate. 
Ghalambor and Heath first suggested the existence of a KDO8P phosphatase that was 
required in the KDO pathway, based on the  inability of KdsB to produce activated KDO 
directly from KDO8P [27]. In 1975, the phosphatase activity specific to hydrolyze 
KDO8P but not A5P or p-nitrophenylphosphate was isolated from E. coli crude extract 
[28]. The wild-type KdsC was first purified and characterized by Ray and Benedict in 
1980 [29, 30]. However, the gene encoding this enzyme was not identified until 2003 
[31]. The recombinant enzyme was characterized and revealed to share similar properties 
with the wild-type enzyme, including metal requirement, substrate specificity, pH 
optimum, kinetic parameters, etc. (Table 1-1).  
 
Table 1-1. Summary of properties of recombinant KdsC as reported by Wu [31] and 
wild-type KdsC as reported by Ray and Benedict [29]. 
 
Property Recombinant KdsC [31] Wild-type KdsC [29] 
KM (μM) 75 91 
Vmax (units/mg) 500 480 
Alternate substrate No No 
Metal requirement Yes Yes 
pH optimum 5.5-7.0 5.5-6.5 
pI 4.6 4.7 
MW (kDa) 
89 (gel filtration) 
23 (SDS-PAGE) 
19.881 (mass spectroscopy) 





Sequence analysis of KdsC revealed that it belongs to the Haloacid Dehalogenase 
Superfamily (HADSF) [31]. The HADSF is one of the largest and most ubiquitous 
superfamilies, including varieties of enzymes catalyzing mostly phosphoryl transfer 
reactions [32]. Four sequence motifs are conserved across the superfamily (Figure 1-4): I) 
DxDxV/T, II) T/Sxx, III) K, and IV) GDxxxD Motifs [32]. Besides these four motifs, 
KdsC also contains a highly conserved signature sequence near the C-terminal region, 
GGxGAxRE, which is not universally conserved in other HADSF enzymes [31]. This 
signature sequence was recently reported to be shared in a close KdsC homolog, 2-keto-
3-deoxy-D-glycero-D-galacto-9-phospho-nononic acid (KDN9P) phosphatase [33]. 
Though the overall sequence homologies between the members of HADSF are low 
(<15%) [34], the structural similarities are high, since a mixed α/β Rossmannoid fold is 
commonly adopted in all the members [32]. In addition, most of the enzymes from this  
 
                                                  Motif I 
                     5          15         25         35         45         55         65      
KdsC gi81170926  MSKAGASLAT CYGPVSADVI AKAENIRLLI LDVDGVLSDG LIYMGNNGEE LKAFNVRDGY GIRCALTSDI  
PSP gi14719642   ---------- ---------- -MEKKKKLIL FDFDSTLVNN ETIDEIAREA ...54mer.. TIKELKNRGY  
BPGM gi124527928 ---------- ---------- ---MKLQGVI FDLDGVITDT AHLHFQAWQQ ...73mer.. LLADLRAQQI  
SPP gi21387099   ---------- -------MER LTSPPRLMIV SDLDHTMVDH HDPENLSLLR FNSLWEHAY- ------RHDS  
PMM gi16877082   ---------- ---MAVTAQA ARRKERVLCL FDVDGTLTPA RQKIDPEVAA FLQKLRSRV- --------QI  
 
 
                  Motif II                     Motif III                  Motif IV 
                     75         85         95        105        115        125        135     
KdsC gi81170926  EVAIITGRKA KLVEDRCATL GITHLYQGQS NKLIAFSDLL EKLAIAPENV AYVGDDLIDW PVMEKVGLSV  
PSP gi14719642   VVAVVSGGFD IAVNKI.... DVEGEVLKEN AKGEILEKIA KIEGINLEDT VAVGDGANDI SMFKKAGLKI  
BPGM gi124527928 SVGLASVSLN APTILAAL.. FCADASQLKN SKPDPEIFLA ACAGLGVP.. IGIEDAQAGI DAINASGMRS  
SPP gi21387099   LLVFSTGRSP ..108mer.. MDLDILPQGA GKGQALAYLL KKLKTEGK.. LACGDSGNDA ELFSIPDVYG  
PMM gi16877082   GVVGGSDYCK ..128mer.. ISFDVFPEGW DKRYCLDSLD QDSFDTIH-- -FFGNE.NDF EIFADPRTVG  
 
 
                 ....|....| ....|....| ....|....| ....|....| ....|....| ... 
                    145        155        165        175        185           
KdsC gi81170926  AVADAHPLLI PRADYVTRIA GGRGAVREVC DLLLLAQG-- -KLDEAKGQ- -SI 
PSP gi14719642   AFCAKPILKE KADICIEKRD LREILKYIK- ---------- ---------- ---  
BPGM gi124527928 VGIGAGLTGA QLLLPSTESL TWPRLSAFWQ NV-------- ---------- ---  
SPP gi21387099   VMVSNAQEEL LKWHAENAKD NPKVIHAKER CAGGIIQAIG HFKLGPNLSP ... 
PMM gi16877082   HSVVSPQDTV QRCREIFFPE TAHEA----- ---------- ---------- --- 
 
Figure 1-4 Sequence Alignment of HADSF enzymes. KdsC: 3-deoxy-D-manno-
octulosonate 8-phosphate phosphatase; PSP: phosphoserine phosphatase; BPGM: β-
phosphoglucomutase; SPP: sucrose phosphate phosphatase; PMM: phosphomannomutase. 
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superfamily require divalent metal ions as cofactors, in many cases Mg2+ [35]. All these 




Figure 1-5 Proposed catalytic mechanism of KdsC. Residues were assigned for E. coli 
KdsC. R = KDO in the α-pyranose form.  
 
The generally accepted mechanism for phosphatases and ATPases in HADSF is 
proposed as two sequential SN2-like reactions [32, 35]. Specifically for KdsC (Figure 1-
5), upon KDO8P binding, an active site aspartate side chain attacks the phosphorus and 
releases the sugar moiety, forming an aspartylphosphate intermediate (mixed anhydride). 
Then a second nucleophilic attack on the mixed anhydride intermediate by an activated 
water molecule releases an inorganic phosphate and regenerates the native enzyme. The 
native substrate form of KDO8P is proposed to be α-pyranose anomer of KDO (Figure 
1-6a) by Baasov and Jakob [37]. The α-anomeric 2-deoxy KDO8P analogue (Figure 1-
6b) retains 50% of the activity of the natural KDO8P, while the β-anomeric 2-deoxy 
KDO8P analogue (Figure 1-6c) has no observable hydrolytic activity [37]. Two 
aspartates in sequence motif I were demonstrated to be essential for enzyme activity via 
8 
mutational studies by Aggarwal [38]. One of these two aspartates should play the role as 
nucleophile and the other as the water-activator. 
 






























Figure 1-6 Anomeric isomers of KDO8P, KDO8P analogues and KDO. a)  α-KDO8P-
pyranose; b) 2-deoxy analogue of α-KDO8P-pyranose; c) 2-deoxy analogue of β-





Figure 1-7 Crystal structure of KdsC from H. influenzae. The cobalt atoms are shown as 
blue spheres. [39] 
 
 
Two crystal structures have been determined for KdsC to date, one from 
Haemophilus infuenzae (PDB ID 1J8D) [39] and the second from a hyperthermal 
organism, Aquifex aeolicus (PDB ID 2P9J). Neither of these structures included substrate, 
products, or the physiological metal magnesium [29, 31] in the active site. KdsC in both 
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crystal structures formed tetramers through interactions between adjacent short β-hairpins, 
each donated from one monomer. Each monomer folded in a basic Rossmannoid core 
(Figure 1-7), without any cap domains as observed in some other HADSF members [34, 
40, 41]. A hexacoordination of the active site divalent metal Co2+ was observed in the H. 
influenzae KdsC cocrystallized with Co2+.  
 
1.3 KdsB 
The enzyme immediately following KdsC in the KDO biosynthetic pathway is the 
CMP-KDO synthetase, KdsB [EC. 2.7.7.38], also known as KDO cytidylyltransferase. 
This enzyme catalyzes the reaction between KDO and CTP to transfers a CMP portion 
onto the KDO moiety, thus making the activated form of KDO that can be later 
transferred onto lipid A. It was initially isolated and studied by Ghalambor and Heath 
[27], and further characterized by Ray and Benedict [42, 43]. E. coli KdsB is specific to 
the β-pyranose form of KDO (Figure 1-6d), as reported in a 13C NMR study by 
Kohlbrenner and Fesik [44]. KDO analogues such as 2-deoxy and 5-deoxy-5-fluoro 
derivatives of KDO were synthesized to study the mechanism of KdsB [45, 46]. CMP-β-
KDO is reported by Sugai et al. to be highly unstable with a half-life of 34 min at 25°C 
[46]. Lin et al. revealed the molecular basis of the fast hydrolysis of CMP-β-KDO which 
adopts a twist-boat conformation in the transition state [47].  Due to the surprisingly short 
half-life, this compound has never been synthesized chemically or isolated from the 
KdsB reaction mixture. Crystal structures of KdsB from H. influenzae [48] and A. 
aeolicus [49] (Figure 1-8) were solved, both revealing a dimeric organization. 
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Figure 1-8 Crystal structure of KdsB from A. aeolicus. [49] 
 
A close homologue of KdsB that shares ~40% sequence identity with KdsB is a 
protein named KpsU. KpsU was reported to be correlated to capsular expression in 
encapsulated E. coli strains [50]. It catalyzes the same reaction as KdsB but with 
distinctly different kinetic properties (Table 1-2) [51, 52]. The crystallographic studies of 
E. coli KpsU by Jelakovic and Schulz also revealed a dimeric structure and a highly 
similar active site to that of KdsB [53, 54]. The capsule is composed of extracellular 
polysaccharide enclosing the bacterium but still attached to the cell. Having KDO 
biosynthetic genes in the capsular-related gene cluster is not surprising, since KDO 
contributes 40-60% of the capsular polysaccharide mass in some species as opposed to 2-
5% of LPS mass [55]. However, to date, only homologues of KdsB (named KpsU) and 
KdsD (named KdsF) were found associated with capsular expression.  
 
Table 1-2 Comparison of kinetic parameters of E. coli KdsB and KpsU. 
 KM KDO (mM) KM CTP (mM) kcat (s-1) 
kcat / KM KDO 
(mM-1s-1) 
KdsBEc [43] 0.29 ± 0.02 0.20 279 ± 9 9.6 x 102 
KpsUEc [52] 2.0± 0.4 2.5 ± 0.5 1.35 ± 0.27 0.7 
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1.4 Dissertation Rationale 
The ultimate goals of this dissertation are to gain mechanistic insights into KdsC 
to guide antibiotic design, and to understand how KdsC may interact with downstream 
enzymes in the pathway. A wide range of techniques and methods were used to achieve 
these goals, including molecular biology, structural biology, enzymology, biochemistry, 
and analytical chemistry.  
In Chapter 2, a set of seven crystal structures are reported for E. coli KdsC and its 
C-terminal “tail-less” variant. For the first time, products of KdsC, KDO and inorganic 
phosphate, are successfully trapped in the active site. Contacts formed between the 
products and the active site residues help define the substrate specificity. A structural 
element that had undergone dramatic conformational change is identified from these 
crystal structures and hypothesized to have an impact on KdsC’s catalytic efficiency. 
This hypothesis was tested by biochemical characterization of an E. coli KdsC C-terminal 
tail deletion mutant as well as KdsCs from other microorganisms which are naturally tail-
less KdsCs, and these results are in Chapter 3. Based on both structural information and 
biochemical characterization, a model of KdsC catalytic cycle has finally been proposed. 
A natively occurring gene fusion of kdsC and kdsB was discovered from database 
mining as the first example of gene fusion in the KDO biosynthetic pathway. The full 
characterization of this fusion gene product is reported in Chapter 4. A coupled 
colorimetric assay was developed to measure both phosphate and pyrophosphate amount 
independently and simultaneously in a reaction mixture to assist in the kinetic analysis of 
this unique fusion protein. 
12 
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Crystal Structures of KdsC and Its Variant 
 
2.1 Summary 
While all four enzymes in the 3-deoxy-D-manno-octulosonate (KDO) 
biosynthetic pathway have been studied for activities, only recently has the gene of 
3-deoxy-D-manno-octulosonate 8-phosphate phosphatase (kdsC) been identified. 
Although the protein product of the kdsC gene has been previously characterized 
biochemically and structures of the protein from two microorganisms have been 
reported, the mechanistic details of KdsC remain unclear. KdsC is a member of the 
haloacid dehalogenase superfamily (HADSF). This phosphatase lacks an essential 
structural element, a cap domain, which is observed in many HADSF members. When 
present, the cap domain is responsible for specific substrate recognition, but 
nonetheless KdsC is highly specific for its substrate, KDO 8-phosphate. To better 
understand this unexpected substrate specificity, studies of the KdsC active site in the 
presence and absence of the substrate or products were pursued. From the crystal 
structures, a dramatic conformational change was observed for the C-terminal tail 
region of E. coli KdsC. Based on this observation, a tail deletion mutant was 
constructed and studied. The catalytic products of the KdsC reaction were observed in 
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the structures of the tail deletion mutant. In total, seven crystal structures of E. coli 
KdsC and its tail-less variant with different metal cofactors, soaked or not with the 
substrate, were obtained. The detailed structural information revealed from my study 
demonstrates an important role for tetramerization in defining the substrate specificity, 




The haloacid dehalogenase superfamily (HADSF) is one of the largest 
superfamilies discovered to date [1]. Members in this superfamily share a similar 
catalytic scaffold that evolved to catalyze mainly the phosphoryl-transfer reactions, 
except for the namesake enzyme [2]. The interest in the HADSF is increasing as more 
enzymes from this superfamily with important biological functions are discovered, 
including the biosynthesis of essential metabolic molecules [3-5], transport [6], signal 
transduction [7, 8], transcription [9] and DNA repair [10]. However, most of the 
HADSF members remain uncharacterized. 
Sequence alignment of the HADSF members suggests four universally 
conserved motifs: I) DxDxV/T, II) T/Sxx, III) K, and IV) GDxxxD [1]. Residues in 
these motifs line up in the active site to participate in catalysis or substrate binding [1, 
4, 6, 11]. Sequence insertions are observed for some HADSF enzymes at either of two 
locations. These insertions form a separate domain extended from the basic 
α/β-hydrolase core (Rossmannoid fold), and are termed the cap domain. The cap 
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domain  can move dynamically in the solvent to either regulate the access to the 
active site, or form a roof over the active site (Figure 2-1) [2]. The HADSF members 
are thereby classified into three groups based on the absence and presence, as well as 
the location of the cap domain [1]. The C0 group members with no sequence insertion 
fold into a single-domain Rossmannoid core. The C1 group, represented by 
phosphoserine phosphatase and β-phosphoglucomutase, has a sequence insertion 
between α/β strand 1 and strand 2 that forms a cap. The C2 group, represented by 
sucrose-6-phosphate phosphatase and phosphomannomutase, has a cap domain 
formed from the sequence insertion immediately after strand 3. The classification of 
KdsC as a HADSF was due to the sequence conservation at the four characteristic 
motifs [12]. The absence of sequence insertions as well as the basic Rossmannoid fold 
structure without cap [13] further assigned this enzyme to the C0 group of HADSF.  
 
C1                                       C2                     C0  
Figure 2-1 Structure of HADSF family members. C1: phosphoserine phosphatase 




Some members of HADSF display broad substrate specificities, while other 
members have narrow substrate specificities [15]. A correlation between substrate 
specificity of the enzyme and the presence of the cap domain has been derived and 
seems due to the substrate specific contacts provided by the cap domain [14]. C0 
group enzymes usually utilize bulky substrates [10] or adopt a wide range of 
substrates [16] with the active sites exposed to the solvent. However, KdsC, the 
archetypical C0 group enzyme, displays a very narrow substrate specificity despite the 
absence of the cap domain [12]. The origin of KdsC’s substrate specificity remains 
elusive. 
To date, two crystal structures of KdsC from Haemophilus influenzae (KdsCHi, 
PDB ID 1J8D) [13] and Aquifex aeolicus (KdsCAa, PDB file 2P9J) have been solved. 
Both structures revealed a tetramer of KdsC stabilized by interactions of short 
β-hairpins inserted between strand 1 and strand 2. Each monomer seems to 
structurally resemble a cap domain over the active site of its adjacent monomer. 
Specific contacts with the substrate, KDO8P, or the products, KDO and Pi, could not 
be deduced since neither reported structure contained the substrate nor the products. 
The location of active site was marked with a hexacoordinated Co2+ in the structure of 
KdsCHi, where all the conserved residues in the four motifs are also present. For E. 
coli KdsC (KdsCEc), the two aspartates in motif I, D32 and D34, were demonstrated 
to be essential for activity through mutational studies [17]. But the details of the 
active site can not be obtained without cocrystallized substrates or products in the 
structure. 
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The high catalytic efficiency [12] and the lack of any strong-binding inhibitor 
of KdsCEc make it challenging to capture the substrate KDO8P in the active site. 
Several strategies can be considered to slow down the reaction rate, therefore 
achieving substrate retention in the active site. One possible strategy involves using 
KdsC from A. aeolicus (KdsCAa), a hyperthermophilic bacteria isolated from a hot 
spring, to represent its mesophilic homolog. Catalytic rates of enzymes from this 
bacterial strain are significantly lower at 4°C given the optimum living temperature is 
95°C [18]. However, KdsCAa was found to be less thermally stable than other 
enzymes from A. aeolicus since it degraded above 60°C, therefore indicating this 
strategy may not apply [17]. An alternate strategy is to use Ca2+ as the cofactor for 
KdsCEc instead of Mg2+, thereby lowering the activity 50 fold [12].       
During our initial efforts to obtain a crystal structure of substrate- or 
products-bound KdsCEc, we observed an unusual substrate-like insertion of the 
C-terminal eight-amino acid region of one monomer into the neighboring monomer’s 
active site thus forming several specific contacts with active site residues. This is a 
unique phenomenon that has not been reported for any HADSF protein structure. A 
deletion mutant removing the eight amino acids from the C-terminus (KdsC∆8) was 
constructed and utilized for crystallography. The catalytic products, KDO and 
inorganic phosphate (Pi), were successfully captured in the active site, enabling the 
identification of the basis for specific substrate recognition. Overall, seven crystal 
structures of KdsCEc and KdsC∆8 with different combinations of divalent metals and 
catalytic products were determined.  
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2.3 Experimental Procedures 
Materials – Tris(hydroxymethyl)aminomethane was obtained from Research 
Organics. Phosphoenolpyruvate mono(cyclohexylammonium) salt, thiobarbituric acid, 
D-arabinose 5-phosphate, sodium arsenate, and bovine albumin serum (BSA) were 
purchased from Sigma-Aldrich Company. BactoTM tryptone was from Becton, 
Dickinson and Company. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was 
purchased from Gold Biotechnology, Inc. Potassium chloride, sodium chloride, yeast 
extract, ampicillin sodium salt, and ammonium sulfate were from Fisher Scientific Inc. 
Plasmid extraction was performed using Wizard® Plus SV Minipreps DNA 
purification kit from Promega Corporation. DNA sequencing was conducted by the 
University of Michigan Biomedical Resources Core Facility. BL21(DE3) E. coli 
strain was from Novagen, EMD Chemicals Inc. Bradford Protein Assay Reagent and 
AG-MPI resin were from Bio-Rad Laboratories, Inc. The Q-sepharose resin, Phenyl 
Superose (HR 10/10) column and FPLC® system were from Pharmacia, GE 
Healthcare. The 3-deoxy-D-manno- octulosonate 8-phosphate synthase (KdsA) from 
E. coli was purified by Jingjing Li in the Woodard laboratory. High grade 
spectra/Por® 7 dialysis tubing (10,000 Da molecular weight cut-off and metal free) 
was from VWR International, LLC. The Millex® syringe driven filter units (0.22 µm) 
was obtained from Millipore.  
Sequence analysis – Database searches of multiple microbial organisms were 
performed utilizing the BLAST program at the NCBI website (http://ncbi.nlm.nih.gov 
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/BLAST). Multiple sequence alignments were generated using Clustal W 
(http://www.ebi.ac.uk/clustalw).  
Protein Concentration Assay – Protein concentration was determined using 
the Bradford assay by using BSA as a standard and mixing 1 mL dye to 10 µL 
proteins. Alternately, ultra-violet absorbance of a protein solution measured at 280 nm 
can be converted into protein concentration, based on the extinction coefficient 
calculated from ProtParam tool (ExPASy).    
Expression and purification of KdsCEc – The pT7-7-kdsCEc plasmid was 
constructed previously. The protein was expressed and purified as described [12]. 
Briefly, the sequenced plasmid was transformed into chemically competent E. coli 
BL21(DE3) cells for expression. The cells were grown in 1L LB media supplemented 
with 100 mg/L ampicillin at 37°C and induced with IPTG at a final concentration of 
0.2 mM when OD600 reached 0.8. The cells were allowed to grow at 17°C after 
induction for another 18 h before being harvested by centrifugation at 6000 rpm in a 
Beckman JA-10 rotor for 10 min. The cell paste was subjected to sonication in buffer 
A (20 mM Tris, pH 7.5) with four pulses of 30 s each with intervals of 2 min in 
between, and clarified by centrifuging at 29,000 g for 30 min. The resultant 
supernatant was passed through Q-sepharose column with a linear gradient elution of 
0-2M KCl in 90 min at 1 mL/min. Fractions containing KdsCEc as identified by 
Bradford assay and SDS-PAGE were eluted at around 0.4-0.6 M KCl, combined, and 
ammonium sulfate was added to 20% (w/v). The protein solution was then loaded on 
a phenyl superpose column (HR 10/10), and eluted with a reverse gradient of 
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ammonium sulfate from 20% to 0% (w/v). Homogenous KdsCEc was collected in 
fractions with 0% ammonia sulfate as identified by SDS-PAGE. The pooled protein 
was dialyzed against buffer A, concentrated to 2.7 mg/mL, and stored at -80°C. The 
total yield was 20 mg/L of cell culture. Proteins were further purified on an S-200 gel 
filtration column equilibrated in 20 mM HEPES pH 7.2, and finally concentrated to 
20 mg/mL using Ultra-15 centrifugal filter unit (Millipore) for crystallization. 
Expression and purification of KdsCΔ8 – The coding sequence for KdsCΔ8 
was constructed by inserting a stop codon in pT7-7-kdsCEc after amino acid residue 
180 using QuickChange Mutagenesis kit. The plasmid pT7-7-KdsCΔ8 was 
transformed into chemically competent E. coli BL21(DE3) cells for expression. 
Protein was overexpressed and purified according to the same procedure as described 
for KdsCEc. Cells were broken in buffer A (20 mM Tris pH 7.5) by sonication and 
centrifuged at 6000 rpm for 10 min in a Beckman JA-10.5 rotor. The supernatant was 
loaded on Q-sepharose column and eluted in fractions with 0.3 ~ 0.6 M KCl. 
Fractions containing KdsC were treated with 25% ammonium sulfate and applied on a 
phenyl-superose column (HR 10/10). Protein eluted at 4% of ammonia sulfate was 
pooled, dialyzed against buffer A, and concentrated to 2.2 mg/mL. A typical yield 
was 20 mg/L of cell culture. The resultant KdsCΔC8 was also further purified on an 
S-200 gel filtration column and concentrated to 20 mg/mL for crystallization. 
Quantification of KDO8P – The Aminoff assay was used to quantitate 
2-oxo-3-deoxy sugars including KDO8P and KDO [19]. In a 10-mL glass culture tube, 
100 µL of appropriately diluted sugar solution was subjected to complete oxidization 
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with 0.2 mL of 0.025 M NaIO4 in 0.25 N H2SO4 at room temperature for 10 min. The 
excess oxidizing regent was reduced by the addition of 0.4 mL of 2% (w/v) NaAsO2 
in 0.5M HCl, indicated by the disappearance of yellow color in the liquid. This 
mixture was then treated with 1 mL thiobarbituric acid (0.36% w/v, pH 9.0) and 
heated at 100°C for 10 min to develop pink color. The amount of KDO8P was 
determined by measuring the absorbance of the reaction mixture at 549 nm (ε = 
1.03×105 M-1cm-1 for the pink chromophore formed between α-formylpyruvate and 
thiobarbiturate).     
Enzymatic synthesis of KDO8P – KDO8P was synthesized through 
enzymatic reaction catalyzed by 3-deoxy-D-manno-octulosonate 8-phosphate synthase 
(KdsA), and purified as described [12, 20]. Equal amounts of D-arabinose 
5-phosphate and phosphoenolpyruvate (100 µmol each) were mixed in 100 mM 
HEPES pH 7 in a volume of 4 mL in the presence of 3.2 mg KdsA. The reaction 
mixture was incubated at 37°C for 16 h without stirring, and quenched with 4 mL of 
10% trichloroacetic acid. Progression of the reaction was monitored by the Aminoff 
assay, and a yield of 82% was achieved. The clarified supernatant was adjusted to pH 
7 with titration of NaOH solutions, and loaded on an AG-MPI anion exchange column 
equilibrated with water. The fractions containing KDO (chemical degradation product 
of KDO8P) and KDO8P were eluted sequentially in 500 mL of 0-400 mM LiCl 
gradient wash, as identified by the Aminoff assay. The latter fractions showing 
positive for Aminoff signal were combined, lyophilized, and reconstituted in 3 mL of 
water. The solution was then passed through a P-2 desalting column, and eluted with 
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water. Fractions positive for the Aminoff assay (indicating the presence of 3-deoxy 
monosaccharides), negative for malachite green assay (indicating the absence of 
inorganic phosphate), and negative for AgNO3 (indicating the absence of Cl-) were 
pooled and lyophilized. The resultant pure KDO8P was dissolved in water, adjusted to 
a concentration of 100 mM, and stored at -80°C for future use.      
Crystallographic experiments and structure determination – All crystal 
forms of KdsC and KdsCΔ8 were grown by hanging-drop crystallizations at 21 oC 
(see Table 2-1). The data were processed with HKL2000 [21]. Initially, data for the 
1.4 Å P1 crystal form were used to determine the structure of KdsC by molecular 
replacement program PHASER [22] using a monomer of KdsCHi [13] as a search 
model. The structure was then iteratively built and refined at 1.4 Å using programs 
COOT [23] and REFMAC [24], respectively. Structures of the other crystal forms 
were determined using this refined structure as a molecular replacement search model 
and then refined analogously. The data and refinement statistics are summarized in 
Table 2-2. Solvent accessible surface area was calculated using program Surface 
Racer [25]. 
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    Table 2-2 Data collection and refinement statistics. 
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Rmerge (%) 3.5 (57.9)a 12.4 (70.0) 12.5 (46.2) 12.9 (40.9) 8.9 (57.0) 7.4 (46.6) 
I/σI 39 (1.6) 22.4 (3.3) 8.9 (2.3) 13.5 (2.2) 19.6 (2.2) 23.0 (3.3) 
Completeness (%) 95 (85) 100 (100) 92.7 (94.2) 98.4 (90.1) 99.2 (94.9) 99.1(96.5) 
Redundancy 3.8 (3.2) 27.7 (22.7) 4.1 (3.9) 5.3 (2.6) 6.8 (4.3) 6.6 (5.4) 
Refinement 
Resolution (Å) 30-1.4 40-2.85 40-2.5 30-2.1 37-1.85 30-2.6 
R/Rfree (%) 16.0/18.8 22.0/27.6 20.6/24.1 18.6/23.1 21.5/24.4 20.3/23.6 
No. of reflections 296631 36441 21494 162029 231079 86138 
R.m.s. deviations 
Bond lengths (Å) 
Bond angles (˚) 
 

















No. of atoms 12808 10844 5442 24342 22566 22256 
No. of  monomers 
per asymm. unit 




Sequence alignment – Homologues of KdsC from various G- organisms are 
compared in multiple sequence alignment (Figure 2-2). All the HADSF motifs are 
conserved. Secondary structures of the species with known crystal structure data are 
consistent with each other.  
 
   
Figure 2-2 Sequence alignment of KdsC homologues. The secondary structure of E. 
coli KdsC is shown schematically above the alignment. Residues involved in the 
tetramerization interface are labeled with black bars (in the β2-β3-hairpin) and black 
circles (outside of the hairpin). Residues coordinating to Mg2+ and contacting with Pi 
are marked with open red circles. Residues involved in KDO recognition are shown as 
the solid red circles. 
 
Preparation of KdsCEc and KdsCΔC8 – Both KdsCEc and KdsCΔC8 were 
overexpressed in E. coli BL21(DE3) cells and purified to homogeneity through two 
chromatographic steps. SDS-PAGE results showed a molecular weight of around 22 
kDa for KdsCEc and 21 kDa for KdsCΔC8 (Figure 2-3). Both proteins were 
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concentrated to 20 mg/mL for crystal growing and resulted in various crystal forms 
[17]. 
 
Std      1        2
31k
21.5k  
Figure 2-3 SDS-PAGE of purified 1) wild-type KdsCEc and 2) KdsCΔC8 with eight 
amino acids DEAKGQSI truncated from the C-terminus 
 
KdsC structures – Seven crystal forms were obtained, with wild-type KdsC 
and its C-terminal tail deletion mutant KdsC cocrystallized with Mg2+ or Ca2+, soaked 
or not with KDO8P (Table 2-2, Figure 2-4).  
 
 
Figure 2-4 A schematic of KdsC structures. Red dots represent Mg2+ ion, orange dots 
for Cl-, and purple dots for Ca2+. The phosphate portion is shown in green sticks and 
the KDO portion is shown in blue sticks. The eight-amino acid tail insertions are 
shown in lines in consistent colors consistent with each monomer.   
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The monomers of KdsC adopt a Rossmannoid fold, as observed in the initial 
structure at 1.4 Å of KdsCEc cocrystallized with its physiological metal Mg2+ (Figures 
2-5). Four monomers organize in a tetramer, similar to previously reported KdsCHi 
[13] and KdsCAa (PDB ID 2P9J) structures. The tetrameric structure is stabilized by 
interactions between β-hairpins from each monomer. The β-hairpins are formed by 
sequence inserts at the same location as the C1 caps but much shorter, and organized 
as a central 8-stranded intermolecular β-barrel mainly through the hydrophobic 
interactions. Conserved residues Leu41, Tyr43, Lue51, and Ala53 are involved in the 
hydrophobic contacts and bury 880 Å2 of solvent accessible surface area per monomer 
in the β-barrel interface.    
      
a) b)
 
Figure 2-5 The tetrameric structure of KdsC in a) the top view and b) the side view. 
The Mg2+ ions are shown in red dots and Cl- shown in orange dots.  
 
The active site cleft of KdsC is formed in the interface between two monomers, 
and is marked with the presence of Mg2+. The metal ion is hexacoordinated (Figure 
2-6) by the side chain of Asp32 and the backbone carbonyl of Asp34, both from 
conserved motif I of HADSF; the side chain of Asp125 from motif IV, and three 
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water molecules, similar to the Co2+ captured in KdsCHi structure [13]. The active site 
cleft is largely lined up with polar and charged residues, including Thr76 from motif 
II and Lys102 from motif III. 
 
Figure 2-6 The 2F0-Fc electron density map of the active site captured in the 1.4 Å 
KdsC structure, contoured at 1 σ. 
 
Binary states of active site – Two tetramers present in the same asymmetric 
unit of the Mg2+-bound KdsC crystal have evident differences in the location of the 
C-terminal tail (Figure 2-4 crystal a and b). In one tetramer, all monomers have the 
tail inserted into the active site of the adjacent monomer and occluded it, resulting in 
all four active sites in a closed states. Besides the Mg2+ ion, one Cl- ion from the 
protein storage buffer is also present in the closed active site, 4.4 Å from the Mg2+, 
indicating a possible location of the Pi binding site. In the other tetramer, all 
C-terminal tails remain disordered, leaving the active sites exposed to the solvent, 
thus being termed the open state. No anion can be found bound in the open state of 
active sites near the metal cofactor Mg2+. In the crystal of Mg2+-bound KdsC soaked 
with KDO8P (Figure 2-4 crystal c), the diagonal pair of active sites remains in closed 
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state while the other diagonal pair is in open state.  The product-bound KdsCΔC8 
active sites are also considered in closed states because solvent is excluded by the 
KDO portion (Figure 2-4 crystal d, Figure 2-8a). In all closed active sites, either a 
scissile phosphate or a Cl- ion is bound, while in all open active sites, no anion is 
present except in the tail-deletion mutant. The tail-in/tail-out conformational change 
also induces corresponding conformational change of the active site loop I and loop II, 
characteristic in displacement of some highly conserved residues including Thr76, 
Lys102 and Arg78 (Figure 2-7). 
 
Figure 2-7 Conformational differences between the open state and the closed state of 
the active site. An open-state monomer from Mg2+-bound KdsC crystal is shown in 
red line and a closed-state monomer from product-bound KdsCΔC8 is shown in blue 
lines. Mg2+ from both monomers are overlapped and shown in a red ball. 
 
Insertion of the C-terminal tail into the active site – In many crystal forms 
of wild-type KdsCEc, the eight-amino acid C-terminal tails are found inserted into the 
active site of the adjacent monomer in trans, resulting in closed states of the active 
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sites. The tail residues make extensive specific contacts with the active site residues, 
especially the three amino acids at the C-terminal end (Figure 2-8a). Generally, the 
carbonyl on the side chain of Gln186 forms a hydrogen bond with Arg63 from the 
same monomer. The hydroxyl group of Ser187 interacts with the backbone carbonyl 
of Val56 from the same monomer. Finally, the terminal carboxylate of Ile188 forms 
salt bridges with Arg86 from the same monomer and Arg78 from the monomer 
possessing the active site. In the structure of Ca2+-bound KdsCEc soaked with KDO8P 
(Figure 2-4 crystal e), a phosphate ion was captured in the tail-in closed active site, 
hydrogen bonding to the backbone carbonyl of Ser187. The active site is stabilized 
through these interactions between the tail and the polar or charged residues. The 




Figure 2-8 a) Specific contacts between the active sites residues and the tail residues 
of the Mg2+-bound KdsCEc. b) Interactions between the active site residues and the 
catalytic products KDO and phosphate in KdsCΔC8. Two adjacent monomers are 
shown in orange and green sticks, respectively. The tail residues shown as pink sticks 
are from the same monomer as the green residues. KDO is in blue sticks and the 
inorganic phosphate is in cyan sticks. Mg2+ is designated as a red dot and Cl- is an 
orange dot. Pictures were made using PyMol. 
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Presence of catalytic products in the active site – Initially, Ca2+ was used as 
the cofactor to slow down the reaction of KdsCEc in the hope of capturing KDO8P in 
the active site. However, only the scissile phosphate was trapped in the active site, 
while the tail residues occupied the rest of the active site cavity. Very interestingly, 
when the tail-deletion mutant KdsCΔC8 was crystallized and soaked with KDO8P, a 
substrate-shaped electron density was obtained in the active sites. After structural 
refinement, the electron density turned out to be the cleaved products, KDO and Pi. 
The tetramer obtained in this structure contains two open-state active sites organized 
diagonally, with Pi and Mg2+ bound, and two closed-state active sites occupied by 
KDO, Pi and Mg2+ (Figure 2-4 crystal d). Pi in these crystal forms is at a similar site 
as Cl- ions in other crystal forms.  
 
Figure 2-9 Scheme of specific interactions of KDO, Pi and Mg2+ in the KdsCEc active 
site. Residues labeled in green are from the adjacent monomer. 
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 The products-occupied active site has the same Mg2+ coordination as 
observed in the tail-occupied active site or the open-state active sites, except that an 
oxygen on Pi coordinates to Mg2+ instead of a water oxygen (Figure 2-9). The 
phosphate ion also makes specific contacts to the main chain amide group of Gly77 
and the side chains of Lys102 and Thr76, all within 3 Å, and to the backbone amide 
group of Val33 through a water-mediated hydrogen bond. 
 
 
Figure 2-10 Omit Fo-Fc electron density map of the active site contoured at 2.3σ. 
 
The presence of the product KDO in the active site was confirmed by an omit 
electron density map (F0-Fc) when excluding KDO and Pi densities (Figure 2-10). 
The conformation of KDO was determined by both the electron density map and 
knowledge of chemical bonding and catalytic mechanism. The hydroxyl group on C8 
of KDO points to the Pi with 2.3 Å distance away from the oxygen on Pi, indicating 
cleavage of the phosphoester bond (Figure 2-9). The KDO sugar is locked in position 
by forming extensive hydrogen-bonding, electrostatic and hydrophobic interactions 
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with enzyme residues, many of which are similar to the contacts made by the tail 
residues (Figure 2-8). Arg78 from the active site and Arg86 and Val56 from the 
adjacent monomer are almost located at the same positions as observed in the 
tail-occupied active sites. The universally conserved Arg78 interacts with O4 and O5 
of KDO and is stabilized by the charge of Glu50 at the same time. Arg86 forms a 
strong salt-bridge with the C1 carboxylate of KDO in the active site of an adjacent 
monomer (in trans), locking the sugar in α-anomeric configuration. Val56 and Leu90 
make hydrophobic interactions with methylene groups at C8 and C3, respectively. An 
evident conformational change can be observed for Arg63, which goes from 
interacting with the side-chain carbonyl of Gln186 on the tail to hydrogen bonding 
with the C2 hydroxyl group on KDO in trans, in both cases through its secondary 
amine group. All the surface-accessible portions of KDO formed specific contacts 
with residues from either monomer, defining a high degree of substrate specificity. 
  
2.5 Discussion 
The position of Mg2+ both herein and in previously reports indicates the 
general location of the active site. However, the location of the substrate or catalytic 
products in the active site was not clear. The Ca2+-bound crystal was originally 
hypothesized to allow substrate trapping by minimizing the catalytic turnover as 
compared to Mg2+-assisted reactions, but contrary to the hypothesis, KDO8P was 
hydrolyzed into products and only Pi was invariably captured in all the active sites. 
When soaking the tail-deletion mutant KdsCΔC8 with KDO8P, catalytic products 
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KDO and Pi were successfully captured in two of the diagonal active sites, and Pi 
alone was observed in the other two diagonal active sites. The structural analysis on 
the products-bound crystal elucidated the details of the active site binding 
environment. Conserved residues Lys102, Gly77 and Thr76 line up in the flexible 
loops to position the Pi molecule, and this position is consistent with an in-line 
nucleophilic attack by an aspartate side chain as observed in other HADSF enzymes 
[26]. Asp32 is highly likely to be the nucleophilic attacking residue, because it 
coordinates to Mg2+ with the side chain carboxylate, and undergoes rotamer change in 
the presence or absence of Pi. This may reflect destabilization of the catalytic center to 
allow product dissociation.  
Multiple crystal forms were obtained in this study, representing various stages 
in the KdsC catalytic cycle. Dramatic conformational changes were observed in two 
region of the enzyme: 1) the C-terminal tail region and 2) the loop I and loop II in the 
active site. The presence of both tail-in and tail-out monomers in the same tetramer 
(Figure 2-4 crystal c) indicates that the active site of free enzyme exists in an 
equilibrium of open and closed state, achieved by the movement of the tail. In the 
active sites closed by the tail, a negative ion is always present, either a Cl- from the 
protein storage buffer or a scissile phosphate from the cleavage of KDO8P, 
suggesting the tail completely excludes solvent from the active site and enables 
locking of a counter ion near the metal cofactor (Figure 2-4 crystals a, c, e, f and g). 
The fact that both products are present in the KdsCΔC8 active site strongly suggests 
that the C-terminal tail is quite possibly involved in regulation of the catalytic rate of 
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KdsC. Conformational changes of loops at the active site corresponds to the tail 
movement. In the tail-in monomer, both loop I (residues 75-80) and loop II (residues 
95-102) were driven closer to the tail, forming a bulge in the active site cavity. The 
same conformational change was observed in the KDO-bound structure of KdsCΔC8, 
in which the KDO portion was locked precisely in the active site by specifically 
interacting with residues on the loops as well as residues on the adjacent monomer. 
Instead of possessing a cap domain as the C1 and C2 group enzymes of 
HADSF, each monomer in the tetrameric KdsC forms a cap-like structure over the 
active site of the adjacent monomer. The tetramerization results in only a narrow 
passage into each active site, and successfully reduces the solvent exposure of the 
active site to a large extent. This is critical to the enzyme activity since solvent 
exclusion is required for formation of the aspartylphosphate intermediate [2]. Another 
role the cap domain plays in HADSF enzymes is to assist in substrate recognition [14], 
and this role is also played by the monomer covering the adjacent active site. Polar 
and nonpolar residues on the neighboring monomer interact with the substrate in trans 
via extensive hydrogen bonding, salt-bridge or hydrophobic interactions, and define 
the substrate specificity. The residues forming direct contacts with KDO include 
Arg63, Arg86, Val56 and Leu90. A very similar organization of polar and nonpolar 
residues was reported for the cap domain of β-phosphoglucomutase, in which Arg49 
forms a charge interaction with a phosphate moiety and backbone of Val47 hydrogen 
bonds to a hydroxyl group of the β-D-glucose 1, 6-phosphate intermediate of similar 
size as KDO8P [14]. Among the KdsC “cap-like” residues, Arg86 interacting with the 
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C1 carboxylate of KDO through electrostatic force is likely the essential residue 
performing the anomeric selectivity. According to studies of Baasov and Jakob using 
2-deoxy analogues of KDO8P, KdsC retains 50% activity when utilizing the 
α-anomer of the KDO8P analogue which has the C1 carboxylate in the equatorial 
position, but has no activity with the β-anomer [27]. 
As a conclusion, the structural analysis revealed the atomic basis of substrate 
specificity supported by both the active site residues and the residues from the 
adjacent cap-like monomer. The tetramerization also facilitates the participation of the 
C-terminal tail in the neighboring active site through conformational change.   
 
2.6 Future Directions 
The residue Arg86 interacting with the C1 carboxylate of KDO in trans is 
likely to play the critical role of defining the anomeric specificity of KDO8P. This 
hypothesis can be further tested through mutational studies. An Asn mutant of 
conserved Arg86 can be constructed and assayed with Baasov’s KDO8P analogues if 
available. Removal of the charge from Arg86 may weaken the selectivity.  
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The Role of the C-terminal Tail of KdsC 
 
3.1 Summary 
An eight-amino acid random coil tail at the C-terminus of E. coli KdsC 
(KdsCEc) undergoes a dramatic conformational change as revealed by crystal 
structures. The transition between the solvent-exposed state and the active 
site-occluded state indicates a possible role for the C-terminal tail in the catalytic 
cycle. Multiple sequence alignments of KdsCs from various microorganisms suggest 
a possible classification of KdsCs into tail-less, random-coiled tailed, and α-helical 
tailed groups. This classification is further supported by the crystal structures of a 
representative from each group. To investigate the function of the tail, a deletion 
mutant of KdsCEc with eight amino acids removed from the C-terminus was 
constructed and annotated as KdsCΔC8. In addition, two enzymes belonging to the 
tail-less KdsC group were prepared for kinetic characterization, one from Aquifex 
aeolicus and the other from Coxiella burnetii. Compared to the full-length KdsCEc, 
the tail-absent KdsCs have similar KM values but 102-103 fold lower catalytic rates 
(kcat), suggesting a critical role of the tail in the catalytic cycle. Combined with 
structural information discussed in Chapter 2, a model of the KdsC catalytic cycle is 
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proposed, highlighted with the active participation of the tail in product release 
through a conformational change. This product release step is the rate-limiting step. 
 
3.2 Introduction 
Structural studies on E. coli KdsC (KdsCEc) revealed a dramatic 
conformational change in the C-terminal region. This random coiled region, formed 
by the eight amino acids from the C-terminus, is flexible in moving in and out of the 
active site of the neighboring monomer, and is therefore termed the “tail” (Figure 
3-1a). It has been reported in other enzymes that small C-terminal domains may play 
regulatory roles through conformational changes between ordered and disordered 
states. One example is the subunit ε in ATP synthase that has a C-terminal α-helical 
tail undergoing conformational change between the hairpin and extended structures, 
which is necessary for ATPase inhibition [1]. Another example is a DNA-mediated 
conformational switch of the C-terminal tail in bacteriophage λ integrase between an  
 
a)                                   b)                         c)
 
Figure 3-1 Comparison of the C-terminal structure of KdsC from a) Escherichia coli 
(2R8E), b) Haemophilus influenzae (1J8D), and c) Aquifex aeolicus (2P9J). All 
C-terminals are colored in red. 
47 
activated trans-packing state and an inactivated cis-packing state [2]. However, this 
phenomenon has never been reported for any haloacid dehalogenase superfamily 
(HADSF) enzyme. 
Interestingly, the two previously solved structures of KdsC from Haemophilus 
influenzae (KdsCHi) [3] and Aquifex aeolicus (KdsCAa, PDB ID 2P9J) have 
conspicuously different C-terminal regions compared to the random coiled extension 
in KdsCEc, although the remaining part of the enzymes, i.e. the Rossmannoid core, are 
almost identical. KdsCHi has a longer C-terminal tail than KdsCEc, and forms a short 
α-helix with residue 162-180 (Figure 3-1b). The significance of this bulky tail has not 
been addressed in any studies. KdsCAa, however, has a sequence ending at the 6th 
α-helix in the Rossmannoid core without an observable C-terminal extension (Figure 
3-1c).  
KdsCAa was studied in the Woodard lab previously [4]. It requires divalent 
metal ion as cofactors, and displays an acidic pH preference (optimum at pH 5), a 
high substrate specificity for KDO8P, and a KM value of 65 µM. All of these 
properties are similar to KdsCEc [5], except that the kcat value of KdsCAa (5.6 s-1) is 
30-fold smaller than that of KdsCEc (175 s-1). Whether the presence or absence of a 
tail plays any role in affecting the catalytic rate remains unclear.  
To further investigate the role of the C-terminal tail in KdsC, the tail-deletion 
mutant KdsCΔC8 used for crystallization was characterized with steady-state kinetics 
in parallel with the full-length KdsCEc and two naturally tail-less forms of KdsC. In 
addition to A. aeolicus, another Gram-negative bacterium, Coxiella burnetii, was 
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found to carry a tail-less kdsC gene using the NCBI database search. This highly 
pathogenic strain is responsible for causing Q fever, a notoriously infectious disease 
occurring in both humans and livestock [6]. A comparison of kinetic behavior of these 
assorted enzymes, KdsCEc, KdsCΔC8, KdsCAa, and KdsCCb, combined with the 
structural information suggest that the C-terminal tail is likely to be involved in the 
catalytic cycle of KdsC by facilitating the second step of product release. This 
regulatory function is achieved by conformational changes of the C-terminal tail.  
 
3.3 Experimental Procedures 
Materials – The genomic DNA of Coxiella burnetii RSA 493 was a generous 
gift from Professor Jim Samuel at Texas A&M University. Malachite green carbinol 
hydrochloride, ammonium molybdate tetrahydrate, molecular weight marker kit, and 
bovine serum albumin (BSA) were purchased from Sigma-Aldrich Company. 
Tris(hydroxymethyl)aminomethane was from Research Organics. BactoTM tryptone 
was from Becton, Dickinson and Company. Anhydrous sodium phosphate monobasic 
was obtained from J. T. Baker Company. Isopropyl β-D-1- thiogalactopyranoside 
(IPTG) was from Gold Biotechnology, Inc. Sulfuric acid, hydrochloric acid, yeast 
extract, sodium chloride, potassium chloride, ammonium sulfate, ampicillin sodium 
salt, NuncTM polystyrene 96-well flat bottom assay microplates, and Fisherbrand 
polystyrene disposable plastic cuvettes were from Fisher Scientific Inc. Polypropylene 
96-well half skirted reaction PCR plates were obtained from DOT scientific, Inc. PCR 
primers were synthesized by Invitrogen corporation. FailSafeTM pre-mix from 
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Epicenter was used as PCR buffer. Plasmid extraction was performed using Wizard® 
Plus SV Minipreps DNA purification kit from Promega Corporation. Restriction 
enzymes, calf alkaline phosphatase and T4 ligase were purchased from New England 
Biolabs, Inc. DNA sequencing was conducted by the University of Michigan 
Biomedical Resources Core Facility. Bradford Protein Assay Reagent, 
Mini-PROTEAN II electrophoresis unit, and microplate reader Model 550 were from 
Bio-Rad Laboratories, Inc. The Q-sepharose resin, Phenyl Superose (HR 10/10) 
column, prepacked HiPrep Sephacryl S-100 (26/60), and FPLC® system were from 
Pharmacia, GE Healthcare. XL1-Blue E. coli strain was from Stratagene, Agilent 
Technologies. BL21(DE3) E. coli strain, BL21-Codon PlusTM(DE3)RIL E. coli strain, 
and HisBind® Ni-NTA resin were from Novagen, EMD Chemicals Inc. High grade 
spectra/Por® 7 dialysis tubing (10,000 Da molecular weight cut-off and metal free) 
was from VWR International, LLC. The Millex® syringe driven filter units (0.22 µm) 
was obtained from Millipore. The 8453 UV-vis diode-array spectrophotometer was 
from Hewlett Packard. All the programmed temperature controls were performed on a 
MJ research PTC-200 Peltier thermal cycler. 
Sequence analysis – Database searches of multiple microbial organisms was 
performed utilizing the BLAST program at the NCBI website (http://ncbi.nlm.nih.gov 
/BLAST). Multiple sequence alignments were generated using ClustalW 
(http://www.ebi.ac.uk/clustalw).      
Protein Concentration Assay – Protein concentration was determined using 
the Bradford assay by mixing 1 mL dye with up to 10 µL of protein. BSA served as a 
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standard. Alternatively, ultra-violet absorbance of a protein solution measured at 280 
nm was converted into protein concentration, based on the extinction coefficient 
calculated from ProtParam tool (ExPASy).    
Expression and Purification of KdsCAa – The A. aeolicus kdsC gene was 
cloned into the pT7-7 vector previously in the Woodard lab [4]. The plasmid was 
transformed into chemically competent E. coli BL21-Codon PlusTM(DE3)RIL cells 
for expression. Cells were grown in 1 L 2×YT culture, and induced with a final 
concentration of 0.2 mM IPTG when OD600 reached 1.6. After growing at 17°C for 18 
h after induction, cells were harvested by centrifuging at 6000 rpm for 10 min on a 
Beckman JA-10.5 rotor, and sonicated in 15 mL of buffer A (20 mM Tris pH 7.5). 
The supernatant was clarified by centrifuging at 15000 rpm for 30 min on a Beckman 
JA-25.5, and divided into two equal portions. Half of the crude extract was subjected 
to a heating procedure according to a previous protocol [7]. Briefly, after addition of 
NaCl to a final concentration of 0.1 M, the crude extract was heated in a boiling water 
bath for 2 min and then heated at 80°C for 8 min with continuous stirring. The 
suspension was separated into supernatant and precipitate, and subjected to 
SDS-PAGE analysis. The unheated portion of crude extract was applied on a 
Q-sepharose column equilibrated with buffer A, and eluted with a 0-2 M KCl gradient 
in 90 min. Fractions containing KdsCAa as judged by SDS-PAGE were pooled and 
treated with ammonium sulfate to a final concentration of 20% (w/v). The protein 
solution was loaded on a phenyl superpose (HR 10/10) column with a reverse elution 
from 20% to 0% (w/v) of ammonium sulfate in buffer A. The fractions containing 
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KdsCAa were eluted around 4% of ammonium sulfate and combined for dialysis 
against buffer A. The resultant protein solution was 1.36 mg/mL and was stored at 
-80°C for future use.  
Cloning and expression of KdsCCb – Genomic DNA of C. burnetii RSA 493 
was quantified by absorbance readings at 260 nm and prepared to a concentration of 
25 ng/µL. The PCR was carried out using the forward primer GATTCTAGAATTC 
ATATGCAAACAACGGCTGAC and the reverse primer GATTTTATTTTATCTTG 
CCTTTGACTGCAGCTTGGATCCGAATTC. The reaction mixture included 25 µL 
FailSafeTM pre-mix K, 1 µL of genomic DNA solution (25 ng/µL), 1 µL each of the 
primers (100 ng/µL), and sterile water up to 49 µL. After heating the reaction mixture 
at 95°C for 2.5 min, 1 µL Vent DNA polymerase was added. The program was set 
with 30 cycles each consisting of denaturation at 94°C for 1 min, annealing at 50°C 
for 1 min and extension at 72°C for 45 s. The PCR product was purified from 1% 
(w/v) low-melt agarose gel and digested with NdeI and BamHI. The expression vector 
pT7-LOH was similarly double digested and treated with calf intestinal alkaline 
phosphatase. The PCR product and the vector are ligated by T4 ligase at room 
temperature overnight. The ligation was transformed into chemically competent 
XL1-blue E. coli cells, which were then spread on an agar plate of LB supplemented 
with 100 mg/L ampicillin (LB/amp). A single colony containing pT7-LOH-KdsCCb 
plasmid, as proved by DNA sequencing, was amplified and stored at -80°C in 25% 
glycerol. 
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The pT7-LOH-KdsCCb plasmid was transformed into chemically competent 
BL21(DE3) for expression. Cells were grown in 2 L of LB/amp media, and induced 
with IPTG to a final concentration of 0.2 mM when OD600 reached 0.9. After growing 
at 17°C for 18 h after induction, the cells were harvested by centrifugation at 6000 
rpm in a Beckman JA-10 rotor for 10 min. The cell paste was lysed in 20 mL 
HisBind® (Novagen) binding buffer (20mM Tris pH8.0, 500mM NaCl, 5mM 
imidazole) by sonication for 30 s for 4 times. The crude extract was then separated 
from the cell debris by centrifuging at 15000 rpm for 30 min in a Beckman JA-25.5 
rotor.  
The supernatant obtained was treated with 10 µL of 10 mg/mL DNase I and 
RNase A each at room temperature for 10 min. After filtration through a 0.22 µm 
Millex® membrane, the crude extract was mixed with 4 mL HisBind® resin (Novagen) 
in a 50 mL centrifuge tube. The resin was saturated with the his-tagged protein by 
rotating the mixture on Labquake® rotator (Barnstead International) at a low speed at 
4°C overnight. The resin/protein mixture was then transferred to a Poly-Prep® column 
(Bio-Rad) for washing, and eluted using column chromatographic techniques. The 
target protein was eluted with 250 mM imidazole in the binding buffer. To avoid 
formation of precipitate after elution, 1 mL of the binding buffer containing 1 mM 
EDTA was added to the collection tube prior to protein elution, and 1 mL of protein 
was collected in each tube. Finally, the pooled protein solution was subjected 
immediately to dialysis against 20 mM Tris pH 7.5 with two buffer changes, initially 
with 1 mM EDTA and later without EDTA. A small amount of precipitate was 
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removed via centrifugation and the solution was tested for protein concentration using 
the Bradford assay. The yield was 10 mg/liter of cell culture. The homogenous 
KdsCCb at 1 mg/mL was stored at -80°C for future use.  
Gel filtration – A Sephacryl S-100 (26/60) column was pre-equilibrated by 
running 20 mM Tris pH 7.5, 150 mM NaCl at 0.4 mL/min for 24 h. Blue dextran, beta 
amylase, alcohol dehydrogenase, albumin, cytochrome C, and carbonic anhydrase 
from the molecular weight marker kit were prepared in solutions of 2 mg/mL and 
each was applied in 1 mL volume on the column by injection into the sample loop. 
The column was washed using the same buffer at 1 mL/min. Retention time of each 
protein was recorded and a calibration curve was plotted. Purified KdsCΔC8 and 
KdsCAa were applied to the column in the same manner as described for the molecular 
weight markers. The molecular weight of the target proteins was then calculated 
based on their retention time and the calibration curve.  
Enzyme assay – KdsC activity was monitored by the malachite green (MG) 
assay for inorganic phosphate (Pi) release [5, 8]. A 0.045% malachite green 
hydrochloride aqueous solution was mixed with 4.2% ammonium molybdate in 4N 
HCl to a ratio of 3:1, stirred at room temperature for 1 h, and passed through 
Whatman No.5 filter paper. To every 100 µL sample, 900 µL MG reagent was added. 
The mixture was transferred into a cuvette and subjected to a UV-vis measurement at 
660 nm after a 5-min color development. The assay can also be adapted to a 96-well 
plate format with modifications in reagent preparation. The reagent was prepared by 
combining 0.09% malachite green hydrochloride aqueous solution and 8.4% 
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ammonium molybdate in 11N HCl to a ratio of 3:1. The mixture was stirred and 
filtered as described for the conventional tube-based measurement. In each well of a 
96-well reading plate, 200 µL of MG reagent was added to 20 µL of sample. After 
incubated at room temperature for 5 min, the plate was read at 655 nm. 
A typical enzyme reaction for KdsCEc, KdsCΔC8 or KdsCCb contained 100 
mM HEPES pH 7, 1 mM MgCl2, 10 µL enzyme, and deionized water up to 50 µL. 
After incubated at 37°C for 1 min, the reaction was quenched with 50 µL 10% 
trichloroacetic acid and subjected to either a conventional tube-based or a 96-well 
plate format MG assay. KdsCAa was assayed the same way except with 2 mM MgCl2 
and an incubation at 60°C.     
Steady-state kinetic measurements – The Pi released in one minute was 
quantified in each reaction containing KDO8P varying from 0 to 2 mM. The initial 
reaction rate (vi) was derived as µmol of Pi production per minute per mg of enzyme. 
The plots of vi vs. KDO8P concentration showed hyperbolic Michaelis-Menten curves, 
and were fit to vi = E0·kcat·S/(KM+S) using the Origin program.  
Salt dependence – Specific activity of KdsCEc, KdsCΔC8 or KdsCCb was 
measured in the presence of NaCl at various concentrations (0-500 mM). Other 
components included in the reaction mixture are as described above. Steady state 






Multi sequence alignment – The hits obtained querying the NCBI database 
against the KdsCEc sequence are identified as putative KdsCs on the basis of the 
conservation of the four HADSF motifs as well as the signature GGxGxxRE sequence 
[5]. Recent work revealed several sequence markers of 2-keto-3-deoxy-D-glycero-D- 
galacto-9-phospho-nononic acid (KDN 9-P) phosphatase, a HADSF enzyme sharing 
>25% sequence identity with KdsC including all the four motifs and the signature 
sequence [9]. These sequence markers in KDN 9-P phosphatase, Glu56 (aligned to 
Arg78 in KdsCEc in multiple sequence alignment) and Lys67 (aligned to Thr89 in 
KdsCEc), are also taken into consideration when identifying possible KdsC from the 
database. The multiple sequence alignment reveals differences in the C-terminal 
region of the KdsC amino acid sequence, thereby leading to the categorization of 
three groups of KdsC (Figure 3-2). The majority of the entries fall into Group 1, 
which is characterized by a short C-terminal extension consisting of eight amino acids 
and is proved to be a random coil based on the structure of KdsCEc. Proteins in this 
group vary in total length, but the C-termini are all aligned on the partially conserved 
eight tail residues. These tails bear abundant hydrophilic side chains, revealing a basis 
for solvent exposure. About 10 species, including Pasteurella multocida, 
Pseudomonas putida F1, Neisseria meningitides 29E, some Haemophilus strains, 
some Mannheimia strains, and some Actinobacillus strains, have KdsC with a long 
C-terminal extension, and are assigned to Group 2 KdsC. This partially conserved 
long tail adopts an α-helical secondary structure as observed in the structure of  
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                 ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....|  
                     5          15         25         35         45         55         65  
E. coli          MSKAGASLAT CYGPVSADVI AKAENIRLLI LDVDGVLSDG LIYMGNNGEE LKAFNVRDGY GIRCALTSDI  
S. enterica      MSKAGASLAA CYGPVSTHVM TKAENIRLLI LDVDGVLSDG LIYMGNNGEE LKAFNVRDGY GIRCALTSNI  
H. pylori        ---------- ---------- ----MIKLLL LDVDGTLTDG SLYFDENFHE IKAFNVKDGL GMTLWQKLGK  
Y. pestis        -MSNTAYIDT CYGPVADDVI QRAANIRLLI CDVDGVMSDG LIYMGNQGEE LKAFNVRDGY GIRCLITSDI  
P. aeruginosa    ---------M SDTHSAAELP VRASRIRLAI FDVDGVLTDG KLYFLVDGSE FKTFNTLDGH GIKMLIASGV  
V. cholerae      ---MSSTVST LYGEVEPSLL EIAKQIKLLI CDVDGVFSDG LIYMGNQGEE LKTFHTRDGY GVKALMNAGI  
 
H. influenzae    ---------- --------MQ QKLENIKFVI TDVDGVLTDG QLHYDANGEA IKSFHVRDGL GIKMLMDAGI  
P. putida (1)    ECLEKVRALI AGQPLTSKP- -KLADIRLVI TDVDGVLTDG GIYYDSTGEC LKRFHVRDGM GMRLLEENGV  
N. meningitidis  ECLERVRAIM SGQLPIDKHS VNLADIRLVI TDVDGVLTDG GIFYNENGEC LKRFHVRDGL GIRLLEESGI  
 
A. aeolicus      ---------- ------MALR DRVKKLKLLI MDIDGVLTDG KLYYTEHGET IKVFNVLDGI GIKLLQKMGI  
C. burnetii      ---------- --MQTTADRQ ERARRIKLLI LDVDGVLTDG RLLYSSRGEI LKVFHVHDGL GIKQLLKAGI  
C. tepidum       ---------- MILLSPQEQQ SRAARIRLVL SDNDGVFTDN GVYYSERGEE FKRYSIRDGM GVERLREHGV  
M. acetivorans   ---------- ---------G TKLKNIKLLI TDVDGVLTDC GMYYSEYGDE LKKFNTRDGM GIQLLREYGI  
  
                 ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| 
                     75         85         95        105        115        125        135 
E. coli          EVAIITGRKA KLVEDRCATL GITHLYQGQS NKLIAFSDLL EKLAIAPENV AYVGDDLIDW PVMEKVGLSV 
S. enterica      EVAIITGRKA KLVEDRCATL GIVHLYQGQS NKLIAFSDLL EKLTIAPENV AYVGDDLIDW PVMEKVGLSV 
H. pylori        KIAIITGRTS IMVKKRMESL GVQFVFMGVE NKNTVIERLK KDLQLSAQEI ACVGDDYNDL GMFKACALSF 
Y. pestis        DVAIITGRRA KLLEDRANTL GITHLYQGQS DKLVAYHELL ATLQCQPEQV AYIGDDLIDW PVMAQVGLSV 
P. aeruginosa    RTAIITGRDT PVVERRARNL GIQHLYQGRE DKLAVLDELL GELGLGYEQV AYLGDDLPDL PVIRRVGLGM 
V. cholerae      EIAIITGRRS QIVENRMKAL GISLIYQGQD DKVQAYYDIC QKLAIAPEQT GYIGDDLIDW PVMEKVALRV 
 
H. influenzae    QVAVLSGRDS PILRRRIADL GIKLFFLGKL EKETACFDLM KQAGVTADQT AYIGDDSVDL PAFAVCGASF 
P. putida (1)    RVAVLSGRDS ATLRKRVTDL GITLHQFGVK DKLKACNQLM EEAGVTAEQT ACIGDDCIDL PAFSACGISF  
N. meningitidis  KVAVLSGRDS PTLRKRIDDL GISYYQLGIK DKHAACIELM QEANCLKEQT AYIGDDTIDL PAFSACGLSF 
 
A. aeolicus      TLAVISGRDS APLITRLKEL GVEEIYTGSY KKLEIYEKIK EKYSLKDEEI GFIGDDVVDI EVMKKVGFPV 
C. burnetii      EVAIISSRKS KAVSRRAAEL GIRHVFQGQP DKRIAFKKLL SQLKLDEKQV AYVGDDLPDL PIMQQVGLAI 
C. tepidum       ETGIMTGEVS PSIVRRAQKL HIERLYLGVK DKQSRLADVL SDTGLSKAEI AYIGDDVNDI GIMNAIA... 
M. acetivorans   KTAIITKENT KIVESRAKKL KVDDVHQGID NKLIVFEELR KKYNLDYSEV VYVGDDINDI PVLEKTGISF 
 
                 ....|....| ....|....| ....|....| ....|....| ....|....| ....|... 
                    145        155        165        175        185        195   
E. coli          AVADAHPLLI PRADYVTRIA GGRGAVREVC DLLLLAQG-- -KLDEAKGQ- -SI----- 
S. enterica      AVADAHPLLI PRADYVTHIA GGRGAVREVC DLLLLAQG-- -KLDEAKGQ- -SI----- 
H. pylori        APFDAHPLLK SKAYKVLQNS GGKGAVREAI DYLLTLEG-- -LQDEALKL- -YL----- 
Y. pestis        AVADAHPLLL PKAHYVTRIK GGRGAVREVC DLILLAQD-- -KLEGATGL- -SI----- 
P. aeruginosa    AVASADPFVR QHAHGVTAAR GGEGAAREFC ELIMRAQG-- -TLEAAQSA- -YL----- 
V. cholerae      CVADGHPLLA QRANYVTHIK GGHGAVREVC DLILQARN-- -ELDVHKGL- -SL----- 
 
H. influenzae    AVADAPIYVK NTVDHVLSTN GGKGAFREMS DMILQAQGKS SVFDTAQGFL KSVKNMGQ 
P. putida (1)    AVADAPVYVK AAATETLLAM GGTGAFREVA DAILCAQGKS AVLLTAAGYA QVMANMAQ 
N. meningitidis  AVADTPEYIR NQADITLTLP GGYGAFRELA DKILAAQGKE DVFSSEAGFA QVMHGANQ 
 
A. aeolicus      AVRNAVEEVR KVAVYITQRN GGEGALREVA ELIHFLKND- ---------- -------- 
C. burnetii      AVTNALPAVQ QQAHWKTRKE GGQGAVREVC DFILSCL--- ---------- -------- 
C. tepidum       ...DAMPLVE PCVHYRCTAQ GGRGAFREYA EWLIALRAS- ---------- -------- 






Figure 3-2 Multiple sequence alignment of KdsC from various Gram-negative 
organisms.  
 
KdsCHi (PDB ID 1J8D). Only a few KdsCs belong to Group 3, which have no 
C-terminal extension compared to KdsCEc or KdsCHi. This group includes only 
Aquifex aeolicus and Coxiella burnetii so far from the database. Some other “tail-less” 
KdsC identified from the database, such as those from Methanosarcina acetivorans, 
Acaryochloris marina, and Chlorobium tepidum, are more likely to be KDN 9-P 
phosphatase based on the sequence markers mentioned above, but the sequences of 
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these strains are still shown in the alignment for comparison. The KDN 9-P 
phosphatases seem to be universally tail-less. 
Phylogenic tree of KdsC – To examine the relationship between the KdsCs 
from the evolutionary perspective, a Phylip-format dendrogram was generated 
(Figure 3-3). The Group 1 and Group 3 KdsCs seem to bifurcate early from a 
co-ancestor not yet discovered. The Group 2 α-helical-tailed KdsCs possibly 
originated from the tail-less KdsCs in Group 3, and then evolved completely 
independently from the Group 1 random-coil-tailed KdsCs. The only exception is the 
KdsC from Helicobacter pylori that is included in the Group 2/3 lobe of the 
phylogenic tree. To avoid sequence bias contributed by the differences in the 
C-termini, all KdsC sequences were truncated from the N-terminus until one amino 
acid before the Motif I and C-terminus for the tail sequences. 
 
Figure 3-3 Phylogenic tree of KdsC from selective microorganisms. The figure was 
generated by ArboDraw software. Shown in pink are Group 2 KdsCs with α-helical 
tails, and in blue are Group 3 tail-less KdsCs. The rest of black are Group 1 
random-coiled tails. 
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Preparation of KdsCAa – Enzymes from A. aeolicus are usually thermostable 
at high temperatures, therefore heating at 85-100°C can be the first step in the 
purification [7, 10]. However, KdsCAa only remained soluble below 60°C [4]. This 
was confirmed in purification trials when crude extracts containing overexpressed 
KdsCAa were heated and KdsCAa co-precipated with the E. coli proteins at high 
temperature. Purified KdsCAa was therefore obtained through two column 
chromatographies performed at room temperature. The yield of homogenous protein 
was 30 mg/L of culture. 
Preparation of KdsCCb – The gene of KdsCCb was cloned into the his-tagged 
vector pT7-LOH and overexpressed as soluble protein. A limited amount of pure 
protein was obtained from the one-step Ni-NTA column purification, because the 
protein precipitated right after elution from the column. This is possibly due to the 
co-elution of Ni2+ ions at high concentration of imidazole that can form complexes 
with several proteins, therefore causing aggregation. Adding EDTA in the collecting 
tube efficiently reduced the precipitation, and reducing the imidazole concentration 
from 500 mM to 250 mM helped enhancing the solubility of the protein without 
affecting eluting efficiency. Finally, a yield of 10 mg/liter of cell culture was 
achieved. 
Oligomerization of KdsC – The Sephacryl S-100 column was first calibrated 
with several proteins of known molecular weight. A linear correlation between 
relative retention time (tx/t0, t0 = retention time for blue dextran) and log of molecular 
weight was derived. The retention time was measured for samples and molecular 
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weight was calculated (Table 3-1). KdsCΔC8 in solution showed a molecular weight 
of 102.5 kDa, indicating a tetrameric structure, since the monomer is calculated to be 
~18 kDa. KdsCAa exhibited a molecular weight of 14.9 kDa, suggesting that although 
the crystal structure revealed a tetrameric construction, the protein in solution remains 
as a monomer. This result agrees with a previous trial [4].  
   
Table 3-1 Molecular weight of KdsCΔC8 and KdsCAa determined from gel filtration. 
 
Protein/Marker Size (kDa) 
Cytochrome C 12.4 
KdsCAa 14.9 
Carbonic anhydrase 29 
Bovine Serum Albumin 66 
KdsCΔC8 102.5 
Alcohol Dehydrogenase 150 
β-Amylase 200 
Blue Dextran 2,000 
 
 
Steady-state kinetics of KdsC – A saturation curve for each reaction was 
measured and non-linearly fit to the Michaelis-Menten equation (Figure 3-4 shows an 
example). Three sets of data were recorded and each hyperbolic curve was fit to 
derive kcat and KM. Mean and standard deviation were calculated for the parameters 
(Table 3-2).  
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Figure 3-4 Saturation curve of KdsCΔC8 plotted with initial velocity vs. 
concentration of KDO8P. Three parallel data sets were measured and individually fit 
to Michaelis-Menten equation. 
 
When the basic kinetic model is assumed (Equation 3-1), KM value obtained 
from the Michaelis-Menten equation fitting can be expressed as Equation 3-2. Since 
both products but not the substrate were captured in the crystal structure of KdsCΔC8, 
the product release must be the rate-limiting step in the catalytic cycle. Therefore it is 
logic to deduce that kcat is much smaller than k-1, thus KM should be close to the 
dissociation constant of the enzyme-substrate complex, KD (Equation 3-3).   
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The KM of KdsCEc is close to the one previously reported [5] (72 vs. 75 µM), 
but the kcat value is 2.6 fold higher (456 vs. 175 s-1), probably due to the inaccurate 
estimation of the enzyme concentration. In the absence of the C-terminal tail sequence, 
KdsCΔC8 has a similar KM (99 µM) but ~102-fold decrease in kcat compared with the 
full-length KdsCEc. Similar KM values and weak catalytic turnover numbers are also 
obtained for the native tail-less KdsC, KdsCAa, ~103-fold lower than KdsCEc. KdsCCb, 
another native tail-less enzyme, has a slightly higher KM (227 µM) but also a low kcat. 
Among all the tested KdsCs, KdsCEc with a tail sequence at the C-terminus has the 
highest catalytic efficiency, while all the tail-less KdsCs have a consistently low 
catalytic turnover number although they remain relatively close in KM. 
  
Table 3-2 Michaelis-Menten parameters of KdsCs. All reactions were carried out in 
100 mM HEPES pH 7 buffer without salt unless marked with asterisk sign. KdsCEc, 
KdsCΔC8, and KdsCCb were measured at 37°C, and KdsCAa was measured at 60°C. 
(*KdsCEc measured with addition of 200 mM NaCl.) 
 
 KM (µM) 
kcat 
(s-1) 
kcat / KM 
(µM-1s-1) 
KdsCEc 72 ± 9 456 ± 17 6.4 ± 0.8 
KdsCEcNaCl* 148 ± 5 145 ± 2 0.98 ± 0.04 
KdsCΔC8 99 ± 9 2.66 ± 0.08 0.027 ± 0.003 
KdsCAa 88 ± 7 0.38 ± 0.02 0.0043 ± 0.0004 
KdsCCb 230 ± 30 1.2 ± 0.1 0.0052 ± 0.0008 
 
Salt effect on KdsC – To test the hypothesis that the hydrophilic tail regulates 
the activity of KdsC through a conformational change, KdsCEc-catalyzed reactions 
were incubated at NaCl concentration varying from 0 to 500 mM and measured for 
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specific activity (Figure 3-5). Activities of the full-length KdsCEc decrease as the salt 
concentration increases, retaining only ¼ the activity when salt concentration is 500 
mM. Indeed, a saturation curve measurement at 200 mM NaCl revealed a 2-fold 
increase in KM and 3-fold decrease in kcat (Table 3-2). However, neither KdsCΔC8 
nor KdsCAa activities are salt-dependent, suggesting that the ionic strength of the 
buffer only affects the tail sequence.  
 











































































Figure 3-5 Salt effect on KdsC. KdsC activities measured in various concentration of 
NaCl. Specific activity is defined as µmol of Pi produced per min per mg of protein. 
 
3.5 Discussion 
KdsC proteins from different microorganisms align with few gaps in the 
middle region, from the conserved motif I containing the catalytic aspartate to the 
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signature sequence near the C-termini. The N-terminal and C-terminal sequences vary 
from species to species. However, according to gene sequences available in the 
current database, the C-terminal regions fall into three patterns: Group 1 the random- 
coiled tail, Group 2 the α-helical tail, and Group 3 without a tail, each represented by 
a crystal structure. The structural comparison reinforces the conspicuous difference in 
the C-terminal region (Figure 3-1). The phylogenetic tree generated from sequences 
of assorted KdsCs also supports this classification. To avoid the bias introduced by 
the varying N-terminal and C-terminal sequence of KdsC, only the middle regions of 
the sequences were submitted for analysis. The phylogenetic tree clearly revealed a 
close relationship between enzymes from the same groups. The tree structure also 
suggests that Group 1 and Group 3 KdsC occur relatively independently in evolution, 
and the Group 1 random-coiled KdsC thrived to be the largest group while the 
tail-less KdsC kept evolving to generate Group 2 long-tailed KdsC at some point. 
Advantages of Group 1 over Group 3 KdsC can be supported by kinetic data.  
KdsCEc, a Group 1 KdsC, is an efficient enzyme characterized by a high 
turnover number (kcat = 456 s-1). The Group 2 representative, KdsCHi, is also a robust 
enzyme with a Vmax value (420 units/mg) comparable to that of KdsCEc (480 units/mg) 
[5]. However, the Group 3 enzymes, KdsCAa and KdsCCb, retain only 10-3-fold of the 
catalytic efficiency (kcat/KM, Table 3-2). Based on the structural model discussed in 
Chapter 2, the extremely low catalytic efficiency of Group 3 KdsC can possibly be 
attributed to the absence of the solvent-exposed and dynamically movable C-terminal 
tail.  
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The tail deletion mutant of KdsCEc, KdsCΔC8, was constructed to probe the 
function of the tail. The KM value of KdsCΔC8 is comparable to that of the full length 
enzyme, which excludes the possibility of tail involvement in the substrate-binding 
step. On the other hand, the kcat value of KdsCΔC8 is 200-fold lower than KdsCEc, 
suggesting that the tail is critical to either the chemistry step or the following products 
releasing step. The latter possibility is supported by the crystal structure of KdsCΔC8 
that captured both KDO and Pi in the active site with the phosphoester bond cleaved, 
suggesting that in the absence of a tail, the product release rate declines. The 
C-terminal amino acids on the tail occupy the same space as the KDO molecule, 
indicating that the tail possibly plays an active role in competing the products out of 
the active site to renew the enzyme. The agreement on the low kcat values of both 
KdsCΔC8 and the native tail-less KdsCAa strongly indicate that the C-terminal tail is 
the major factor affecting catalytic efficiency of KdsC. 
The hypothesis of the tail affecting the catalytic rate by helping both KDO and 
Pi release is based on the assumption of the feasibility of conformational change. It is 
demonstrated in the crystal structures of Mg2+-bound KdsCEc that the tail can exist 
either in a completely disordered conformation exposed to the solvent or in an ordered 
conformation locked in the active site of the adjacent monomer via specific 
interactions with the active site residues, especially two salt-bridges between Arg86 
and Ile188 (Chapter 2). The driving force for this conformational change is unknown, 
but it is possible that the tail distributes between these two states at a certain 
probability ratio. The ionic strength of the buffer may result in a shift of the 
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probability distribution between the two states if electrostatic interactions participate 
in the rate-limiting step. An increase in salt concentration will generate more ions to 
compete with the tail in the active site binding pocket, making the hydrophilic tail 
more favorably exposed in the buffer. If the transition of the tail from solvent-exposed 
to active site-bound state is rate-limiting, higher salt concentration will slow down the 
product release step. Oppositely, if the conformational change from ordered to 
disordered state is rate-limiting, concentrated salt in the buffer will accelerate the 
reaction. Indeed, the activity of KdsCEc decreases as NaCl concentration increases 
(Figure 3-5), suggesting that the tail insertion is the rate-limiting step. Consistent with 
this speculation, for KdsCs without a tail, including both the KdsCΔC and KdsCAa, 
activities are independent of salt concentration.  
For tails to interact in trans with the neighboring active site, a tetrameric 
structure of KdsC has to be maintained (Chapter 2). KdsCEc was proven to be a 
tetramer in solution [5], and the removal of tail did not change the oligomerization 
state (Table 3-1). However the molecular weight of KdsCAa determined from gel 
filtration chromatography suggests a monomeric structure in solution. Although the 
crystal structure reveals a tetramer, this could possibly be due to the intensive packing 
of molecules. It is natural to deduce that the substrate binding in KdsCAa would be 
lowered in the absence of a neighboring monomer which is known to provide 
substrate contacts from the structural studies in Chapter 2. However, the KM value of 
KdsCAa is within the same level as that of KdsCEc, indicating that either the KdsCAa 
monomers self-assemble upon substrate binding in solution or the specific contacts 
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provided by the cap monomer do not lower the binding energy significantly. Further 
mutational studies on the cap monomer are required to clarify these points.  
 
 
Figure 3-6 Model of KdsC catalytic cycle. Closed monomers are in red while open 
monomers are in green. Mg2+ ions are represented by red dots. KDO8P molecules are 
represented by long blue squiggles and KDO molecules are short blue squiggles. Pi 
molecules are green dots.  
 
Based on all the biochemical characterization discussed in this chapter and the 
structural information revealed in Chapter 2, a model of KdsC catalytic cycle can be 
proposed as follows (Figure 3-6). Empty monomers of KdsC exist in the equilibrium 
of open states and closed states, according to the tail-out and tail-in conformation. In a 
tetramer, the four active sites can adopt all-in, all-out, or diagonal pair-wise  
in/out states. The substrate KDO8P can only bind to the cleft between the open state 
monomer and a cap monomer, when the tail from the cap monomer is exposed to the 
solvent thus generating a passage for the substrate to enter the active site. Substrate 
binding can induce a conformational change in the active site by rearrangement of 
two loops to fit the shape of the substrate. A similar induced-fit change also occurs 
when the tail binds to the active site. The substrate is cleaved in the completely 
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solvent-exclusive active site, and the KDO sugar molecule is released first. A tail 
from the cap monomer inserts into the substrate binding cleft, occupies the vacancy 
left by KDO, and forms similar specific contacts as the KDO does with the residues 
from both monomers. Finally, the transition from the tail-closed active site to open 
state is accompanied by Pi release to generate the reactivated enzyme. Release of 
KDO and Pi are possibly rate-limiting, since both products are captured in the active 
site of the substrate-soaked KdsCΔC8 crystal. In addition, in the absence of tail, the 
proposed product-release facilitator, the catalytic rate is reduced to a large extent. 
Tetramers labeled with letters a-g in Figure 3-6 are supported by the corresponding 
structure snapshots in Figure 2-4. 
In conclusion, the C-terminal extension in Group 1 KdsC is confirmed to play 
a critical role in the catalytic cycle through a conformational change, very possibly by 
facilitating product release. The discovery of this regulatory mechanism is novel in 
HADSF systems.  
 
3.6 Future Directions 
Tail residues form specific interactions with the active site residues, especially 
the last three amino acids on the C-terminus, Gln186, Ser187 and Ile188. Removal of 
the hydrophilic side chain of Gln186 and/or Ser187 may raise the energy of the tail-in 
state, and cause a decrease in catalytic efficiency. If this statement is true, it will 
support the speculation that the movement of tail is driven by the distribution of 
probability into all possible states, otherwise it will suggest another driving force. 
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Shortening the tail may alter the flexibility of the tail and also reduce the catalytic rate. 
These hypotheses can be tested by mutagenesis studies. The function of tail can also 
be verified by adding a tail of KdsCEc to a tail-less enzyme. 
 
3.7 Acknowledgements 
Genomic DNA of C. burnetii RSA 493 was a generous gift from Professor Jim 
Samuel at Texas A&M University. KdsC from Aquifex aeolicus was cloned by former 
graduate student Parag Aggarwal in the Woodard group. I thank Professor Oleg 





1. Feniouk, B.A., T. Suzuki, and M. Yoshida, The role of subunit epsilon in the 
catalysis and regulation of FOF1-ATP synthase. Biochim Biophys Acta, 2006. 
1757(5-6): p. 326-38. 
 
2. Aihara, H., H.J. Kwon, S.E. Nunes-Duby, A. Landy, and T. Ellenberger, A 
conformational switch controls the DNA cleavage activity of lambda integrase. 
Mol Cell, 2003. 12(1): p. 187-98. 
 
3. Parsons, J.F., K. Lim, A. Tempczyk, W. Krajewski, E. Eisenstein, and O. 
Herzberg, From structure to function: YrbI from Haemophilus influenzae 
(HI1679) is a phosphatase. Proteins, 2002. 46(4): p. 393-404. 
 
4. Aggarwal, P., Validating the Kdo Pathway as a Potential Novel antimicrobial 
Target: Analysis of Kdo8P Phosphatase, in Medicinal Chemistry. 2007, 
University of Michigan: Ann Arbor. p. 13-33. 
 
5. Wu, J. and R.W. Woodard, Escherichia coli YrbI is 
3-deoxy-D-manno-octulosonate 8-phosphate phosphatase. J Biol Chem, 2003. 
278(20): p. 18117-23. 
 
6. Maurin, M. and D. Raoult, Q fever. Clin Microbiol Rev, 1999. 12(4): p. 
518-53. 
 
7. Duewel, H.S., S. Radaev, J. Wang, R.W. Woodard, and D.L. Gatti, Substrate 
and metal complexes of 3-deoxy-D-manno-octulosonate-8-phosphate synthase 
from Aquifex aeolicus at 1.9-A resolution. Implications for the condensation 
mechanism. J Biol Chem, 2001. 276(11): p. 8393-402. 
 
8. Lanzetta, P.A., L.J. Alvarez, P.S. Reinach, and O.A. Candia, An improved 
assay for nanomole amounts of inorganic phosphate. Anal Biochem. Vol. 100. 
1979. 95-7. 
 
9. Lu, Z., L. Wang, D. Dunaway-Mariano, and K.N. Allen, Structure-function 
analysis of 2-keto-3-deoxy-D-glycero-D-galacto-nononate-9-phosphate 
phosphatase defines specificity elements in type C0 HAD family members. J 
Biol Chem, 2008. 
 
10. Batchelor, J.D., M. Doucleff, C.J. Lee, K. Matsubara, S. De Carlo, J. Heideker, 
M.H. Lamers, J.G. Pelton, and D.E. Wemmer, Structure and Regulatory 
Mechanism of Aquifex aeolicus NtrC4: Variability and Evolution in Bacterial 










The carbohydrate KDO (3-deoxy-D-manno-octulosonate) is not only an essential 
linker molecule that anchors repeating oligosaccharides to lipid A to form the 
lipopolysaccharide (LPS) layer in Gram-negative bacteria but also a major component in 
the capsular polysaccharide region. Four enzymes, KdsD, KdsA, KdsC and KdsB, are 
involved in the LPS KDO biosynthetic pathway. The genes encoding these enzymes are 
usually dispersed throughout the bacterial genome as opposed to being localized on a 
common operon. On the other hand, the kps genes involved in capsular biosynthesis and 
assembly commonly reside in a cluster. In the kps cluster, only the kdsD and kdsB 
homologues of the KDO biosynthetic pathway are present. To date, no gene fusion in 
either of the pathways has been reported. Here we report a fusion of kdsB and kdsC genes 
in Pseudomonas putida F1, annotated as kdsBC, discovered through a BLAST search of 
the NCBI database. This gene fusion is unique, and more interestingly, it resides in a 
gene cluster comprised of both kds and kps genes. The putative bifunctional enzyme 
encoded by this naturally occurring fusion gene was cloned, expressed and characterized. 
The separate KdsB and KdsC domains of KdsBC were also cloned, expressed and 
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characterized.  A combined colorimetric method was established to study the coupled 
activity of KdsBC by monitoring phosphate released by KdsC and pyrophosphate 
released by KdsB, independently and simultaneously. The fusion protein displayed both 
KdsC and KdsB activities with the KdsB displaying the rate-limiting activity. Overall, the 
covalently linked fusion protein is more efficient than the mixture of individually cloned 
KdsB and KdsC domains. 
 
4.2 Introduction 
The C-terminal tail of E. coli KdsC was found to be a structural element that 
actively participates in the catalytic cycle. The A. aeolicus KdsC, which natively lacks the 
C-terminal tail, displays a lower catalytic activity. I hypothesized that the absence and 
presence as well as the length of the tail may allow categorization of KdsC into groups. 
To test this hypothesis, I searched the NCBI database to examine various KdsC 
sequences. The amino acid sequence alignment revealed three distinctive groups of tails: 
short tail, long tail, and no tail. Interestingly, in a BLAST search for conserved domains 
using E. coli KdsC as a query, two examples of a gene fusion of KDO8P phosphatase 
(kdsC) and CMP-KDO synthetase (also known as KDO cytidylyltransferase, kdsB) were 
discovered, both annotated as kdsBC. One fusion gene was found in Pseudomonas putida 
F1 (locus tag: Pput_3909), and the other was found in Neisseria meningitidis serogroup 
29E (gene name: cap29eG). The protein product of these fusion genes, if unmodified by 
post-translational cleavage, should lead to a covalently linked KdsB and KdsC on a single 
polypeptide chain.  
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Although it is common for genes from the same pathway to form a cluster, the 
kdsDACB genes in the KDO biosynthetic pathway are usually dispersed throughout the 
genome, with the occasional exception of kdsC and kdsD which locate sequentially in the 
genome map of some microorganisms. However, no gene fusion has been previously 
reported in the pathway. Results from a NCBI database search revealed that out of the 
300 entries of microorganisms that carry kds genes, only 10 species have the kdsDACB 
genes residing closely or forming a gene cluster (Table 4-1, Figure 4-1acd). None of 
these examples have been studied. It is quite exciting to discover that both the kdsBC 
fusion genes in my study are found in a kds cluster.  
 
Table 4-1 List of all microorganisms possessing the kds gene cluster. Data were collected 
from the NCBI database as of 9/30/08. Locus tag prefixes are shown in parentheses in the 
first column, with the asterisk marks (*) standing for the numbers listed in column 2-5. 
The dagger signs (†) mark the fusion genes. 
 
Microorganism (Locus tag) kdsA  kdsB  kdsC  kdsD  
Pseudomonas putida F1 
(Pput_*)  3908  3909
†  3909†  3910  
Neisseria meningitidis 
Serogroup 29E (Cap*) 29eF 29eG
† 29eG† 29eH 
Ralstonia metallidurans 
(Rmet_*)  5733  5734  --  5735  
Synechococcus elongatus 
PCC7942 (Synpcc7942_*)  2289  2290  2288  2291  
Synechococcus elongatus 
PCC6301 (syc*_d)  1811  1810  1812  1809  
Synechococcus sp. WH8102 
(SYNW*)  0180  0184  0186  0187  
Synechococcus sp. CC9902 
(Syncc9902_*)  0206  0209  0210  0211  
Synechococcus sp. WH7803 
(SynWH7803_*)  0231  0233  0237  0238  
Methylacidiphilum 
infernorum (Minf_*)  0954  0956  --   --  
Prochlorococcus marinus 
MIT 9303 (P9303_*1)  2556  2553  2551  2550  
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The eight-carbon carbohydrate molecule, KDO, serves as a linker molecule in the 
lipopolysaccharide (LPS) layer in Gram-negative bacterial outer membrane, and 
comprises 2% of the LPS [1]. Many G- strains, such as E. coli, and some G+ strains, such 
as Bacillus megaterium, contain an extracellular envelope or capsule attached outside of 
outer membrane. The capsule is mainly composed of the K-antigen polysaccharide (KPS) 
which is responsible for protecting bacteria against phagocytosis [2, 3]. In some 
encapsulated E. coli [4-9] and other Gram-negative bacteria [10-15] such as 
Actinobacillus pleuropneumoniae ,  Burkholderia pseudomallei ,  Moraxella 
nonliquefaciens, etc., KDO is found as a common building block in repeating 
oligosaccharides and makes up 40-60% of the KPS content. Among the different types of 
capsules in E. coli strains, those containing KDO in the KPS are classified as Group 2 
capsule. Genes responsible for Group 2 capsular biosynthesis and assembly were 
annotated as kps and cluster in a fixed pattern of kpsFEDUCS [16], represented by E. coli 
CFT073 genes shown in Figure 4-1b. These genes not only cluster together, but also 
form enzyme complexes in some examples [17-19], but no gene fusion has been reported. 
The functions of the kpsEDCS genes remain unclear but are correlated to capsule 
expression [17]. The other two genes, kpsF and kpsU, are homologues to kdsD and kdsB, 
respectively. Each homologous pair shares high sequence (~40%) and functional identity 
[16, 20]. KdsB and KpsU are two isozymes of CMP-KDO synthetase (CKS) and 
designated as L- (LPS) and K- (KPS) CKS, respectively. Accordingly, KdsD and KpsF 
are annotated as L- and K-D-arabinose 5-phosphate isomerase (API), respectively [20]. In 
the kps cluster, the absence of homologues of the other two essential KDO pathway genes, 
kdsA and kdsC, is quite counterintuitive because it suggests that the only copy of kdsA 
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which is outside the kps cluster needs to produce enough KDO 8-phosphate to supply 
both the LPS and the KPS KDO biosynthesis, when both the outer membrane and the 
capsule are present. Interestingly, the heavy metal-dependent G- bacterium, Ralstonia  
 
b) E. coli CFT073
kpsF kpsE kpsD kpsU kpsC kpsS
c) R. metallidurans
kpsD kpsE kdsA kpsU kpsF kpsC kpsS
kpsE kpsD kdsA kdsBC kpsF kpsC kpsS
d) P. putida F1
kdsD kdsB kdsA kdsC
a) S. elongatus PCC6301
Fusion gene
 
Figure 4-1 Organization of kds and kps gene clusters. a) kds cluster of Synechococcus 
elongatus PCC6301 is shown as an example of Synechococcus strains that possess kds 
cluster without insertions of other genes. b) kps cluster of E. coli CFT073 is shown as an 
example of group 2 capsule gene organization. c) A kdsA gene inserts into the kps cluster 
on genome of Ralstonia metallidurans. The blue box highlights the genes that have KDO 
biosynthetic pathway activities. d) A kdsA and a kdsC insert into the kps cluster on the 
genome of Pseudomonas putida F1 with the latter fused with a kpsU gene. The fusion 
gene is annotated as kdsBC. The blue box highlights a complete set of genes that have all 
four KDO biosynthetic pathway activities. 
 
 
metallidurans [21], has a kdsA inserted into the kps cluster (Figure 4-1c). This insertion 
is unique. This kdsA gene is the only copy of kdsA in the genome and has yet to be 
characterized. Also, the level of KDO expression in this strain is unknown. Therefore, it 
is not clear how this enzyme works to produce enough KDO for both polysaccarides. 
Even more intriguing, a complete set of kds genes seems to incorporate into a kps cluster 
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in P. putida F1, organized as kdsA and kdsBC fusion in the forward orientation, and kdsD 
in the reverse orientation (Figure 4-1d). After comparing these genes to their 
homologues in E. coli CFT073 (Table 4-2), the kdsB portion of the kdsBC is shown to 
share more sequence identity with E. coli kpsU than kdsB (Figure 4-2a). Similarly, the P. 
putida F1 kdsD in the cluster should instead be annotated as kpsF (Figure 4-2b). 
Therefore, the overall gene organization in this region is a full set of kps genes into which 
a kdsA and a kdsC gene has been inserted, with the latter fused to a kpsU. The fusion gene 
will still be annotated as kdsBC for convenience.  
Table 4-2 Comparision of each kds gene from the kps/kds gene cluster in P. putida F1 to 
its homologue(s) in E. coli CFT073 via pairwise sequence alignment.  
 
 P. putida F1 Copy 1 E. coli CFT073  Identity  
KdsD  Pput_3910 
c3957 (KdsD) 
c3686 (KpsF)  
46% 
52%  
KdsA  Pput_3908  c1674  72%  
KdsC  Pput_3909 c3958 38% 
KdsB  Pput_3909 
c1058 (KdsB) 












a)                                                             b)
 
Figure 4-2 Unrooted phylogenic tree of KdsB/KpsU and KdsD/KpsF. a) Comparison of 
KpsU and KdsB from E. coli CFT073 to KdsBs from P. putida F1; KdsB1 is part of the 
sequence of KdsBC fusion protein. b) Comparison of KpsF and KdsD from E. coli 
CFT073 to KdsDs from P. putida F1; KdsD1 is the copy in the kds/kps cluster. The 
phylip-format dendrograms are generated by Biology WorkBench 3.2. 
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P. putida F1, a Gram-negative bacterium originally isolated from a polluted creek 
in Urbana, IL, is capable of growing on a wide range of aromatic hydrocarbons such as 
toluene, benzene and trichloroethylene, thus detoxifying these environmental pollutants 
[22-24]. Besides the kdsA and kdsC inserted into the kps cluster, the F1 substrain carries a 
second set of all four kds genes which are dispersed throughout the genome. Each 
homologous pair of genes shares high degree of sequence identity with each other (Table 
4-3). Possessing two complete sets of kds genes is unique. All other substrains of P. 
putida with complete and available genomic data possess only the dispersed set of kds 
genes, and have no fusion gene. The clustered kds genes are likely to be the capsular 
polysaccharide KDO biosynthetic genes since they reside in a kps cluster. On the other 
hand, the dispersed kds genes can be assigned as the LPS KDO biosynthetic genes, 
because both kdsB and kdsD from this set share more sequence identity with the kds 
genes instead of the kps homologues in E. coli CFT073 (Figure 4-2). 
 
Table 4-3 Comparison of the two sets of KDO biosynthetic enzymes from Pseudomonas 
putida F1 via pairwise sequence alignment. Genome locus tag and length of peptide 
chain are listed for each enzyme. 
 
 P. putida F1 Copy 1  P. putida F1 Copy 2  Identity  
KdsD/KpsF  Pput_3910 Pput_0996 49%  
KdsA  Pput_3908  Pput_4166 70%  
KdsC  Pput_3909 Pput_0995 39%  
KdsB/KpsU  Pput_3909 Pput_3812 48%  
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The N. meningitidis serogroup 29E is known to be relatively low in pathogenicity 
compared to other serogroups of N. meningitidis [25], however it is less susceptible to 
penicillin than other N. meningitidis serogroups [26]. The 29E strain is the only 
serogroup in N. meningitidis species that contains KDO in the capsular polysaccharides 
[27]. The four kds genes lay tandem on the genome, similar to the gene organization in 
the kds/kps cluster in P. putida F1. However, in N. meningitidis serogroup 29E, kdsD and 
kdsB genes are present instead of kdsF and kpsU, and no kps cluster is observed in the 
region near these kds genes in N. meningitidis serogroup 29E. Since this strain has not 
been completely sequenced, there is no evidence for the existence of a set of dispersive 
kds genes.  
The kdsBC from P. putida F1 was chosen to study because of the uniqueness of 
the potential fusion of two kds genes, as well as the special location of the gene as 
described above. This gene may represent a critical evolutionary stage of the KDO 
biosynthetic pathway. The protein product of this gene may display fused KdsC and 
KdsB activities with intriguing catalytic properties. In addition, this putative bifunctional 
enzyme could potentially serve as a model for studying protein-protein interaction in the 
KDO biosynthetic pathway.  
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The putative bifunctional protein should catalyze first the hydrolysis of KDO8P to 
release one equivalent of phosphate (Pi) and KDO, followed by reaction of the KDO with 
CTP to allow the addition of CMP onto KDO. The latter transformation should be 
accompanied by the release of one equivalent of pyrophosphate (PPi) (Figure 4-3). 
Phosphatase activities are usually measured by monitoring Pi release using various end 
point colorimetric [28, 29] and continuous methods [30, 31]. The CMP-KDO synthetase 
activities can be measured by following CMP-KDO production via a modified Aminoff 
assay ([32]). This multi-step method eliminates the contamination of the substrate KDO 
by reducing it with sodium borohydride, leaving only the KDO portion of CMP-KDO 
(the KDO in this molecule is stable to borohydride treatment) to generate a colorimetric 
signal through periodate oxidation followed by thiobarbituric acid addition. To avoid this 
time-consuming method, I chose to monitor PPi production in the reaction. Generally, PPi 
can be converted into two molecules of Pi by inorganic pyrophosphatase and analyzed as 
total Pi [33-35]. Alternatively, the PPi producing enzyme can be coupled to PPi-dependent 
fructose-6-phosphate kinase, fructose-1,6-diphosphate aldolase, triosephophate isomerase, 
and glycerophosphate dehydrogenase consecutively, and finally monitored by the 
absorbance change at 340 nm for the oxidation of NADH to NAD+ [36, 37]. A molecule 
of Pi is generated as a by-product in the reaction catalyzed by the fructose-6-phosphate 
kinase. To assay KdsBC, I wanted to monitor both Pi and PPi production to acquire 
information for both activities simultaneously. The methods of PPi detection mentioned 
above all generate extra Pi, and therefore would interfere with the Pi assay for the KdsC 
portion of the reaction, thus losing the information about Pi generated from the KdsC 
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reaction. Developing an assay capable of determining the amounts of Pi and PPi from a 
reaction mixture was a major experimental challenge.  
The strategy chosen was to combine two colorimetric assays: 1) the commonly 
used malachite green assay (MG) that detects only Pi [38, 39], and 2) the colorimetric 
assay based on ammonium molybdate and eikonogen reagent (EK) that detects both Pi 
and PPi independently and “simultaneously” [29, 40] (Figure 4-4). If a sample is to be 
analyzed for both Pi and PPi, Pi can be directly determined using the MG assay. The PPi 
can be calculated by subtracting the concentration of Pi determined by MG from the EK 
signal which is the combined signal of both Pi and PPi. However, it was unclear whether 
Pi and PPi could compete for any reagent in the color development mixture and thus 
interfere with each other in chromophore formation. Only when the chromophore 
formations of Pi and PPi are independent can both species correlate linearly to absorbance.  
Also, since the combination of two assays, MG and EK, may result in error accumulation, 
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Figure 4-4 Scheme of reactions in a) EK color development and b) the MG assay 
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With the enzyme of interest and assay method identified, the bifunctional KdsBC 
from Pseudomonas putida F1 (annotated as PpBC) was cloned, overexpressed and fully 
characterized. Each individual domain (annotated as PpB for the KdsB domain and PpC 
for the KdsC domain, Figure 4-5) was also cloned and isolated, and characterized to 

























4.3 Experimental Procedures 
Materials – The Pseudomonas putida F1 strain (ATCC 700007) was purchased 
from American Type Culture Collection. Malachite green carbinol hydrochloride, 
ammonium molybdate tetrahydrate, sodium sulfite, sodium metabisulfite, Trizma® base, 
sodium pyrophosphate tetrabasic decahydrate, pyrophosphate reagent and bovine serum 
albumin (BSA) were purchased from Sigma-Aldrich company. Tris(hydroxymethyl) 
aminomethane was from Research Organics. BactoTM tryptone was from Becton, 
Dickinson and Company. Nutrient broth powder was from Difco Laboratories, Inc. 
Anhydrous sodium phosphate monobasic and 2-mercaptoethanol were obtained from J. T. 
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Baker Company. Isopropyl β-D-1-thiogalactopyranoside was from Gold Biotechnology, 
Inc. Sulfuric acid, hydrochloric acid, yeast extract, sodium chloride, potassium chloride, 
ammonium sulfate, ampicillin sodium salt, NuncTM polystyrene 96-well flat bottom assay 
microplates, and Fisherbrand polystyrene disposable plastic cuvettes were from Fisher 
Scientific Inc. Polypropylene 96-well half-skirted reaction PCR plates were obtained 
from DOT scientific, Inc. The 1-amino-2-naphthol-4-sulfonic acid was purchased from 
Mallinckrodt Chemical Works. PCR primers were synthesized by Invitrogen Corporation. 
FailSafeTM pre-mix from Epicenter was used as PCR buffer. Plasmid extraction was 
performed using Wizard® Plus SV Minipreps DNA purification kit from Promega 
Corporation. Restriction enzymes, calf alkaline phosphatase, Vent DNA polymerase, Pfu 
DNA polymerase and T4 ligase were purchased from New England Biolabs, Inc. DNA 
sequencing was conducted by the University of Michigan Biomedical Resources Core 
Facility. Bradford Protein Assay Reagent, Mini-PROTEAN II electrophoresis unit, and 
microplate reader Model 550 were from Bio-Rad Laboratories, Inc. The Q-sepharose 
resin, Phenyl Superose (HR 10/10) column and FPLC® system were from Pharmacia, GE 
Healthcare. XL1-Blue E. coli strain was from Stratagene, Agilent Technologies. 
BL21(DE3) E. coli strain and HisBind® Ni-NTA resin were from Novagen, EMD 
Chemicals Inc. High grade spectra/Por® 7 dialysis tubing (10,000 and 15,000 Da 
molecular weight cut-off and metal free) was from VWR International, LLC. The 
Millex® syringe driven filter units (0.22 µm) was obtained from Millipore. The 8453 UV-
vis diode-array spectrophotometer was from Hewlett Packard. All the programmed 
temperature controls were performed on a MJ research PTC-200 Peltier thermal cycler. 
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Sequence analysis – Database searches of multiple microbial organisms were 
performed utilizing the BLAST program at the NCBI website (http://ncbi.nlm.nih.gov/ 
BLAST). Multiple sequence alignments were generated using Clustal W 
(http://www.ebi.ac.uk/clustalw).  
Protein Concentration Assay – Protein concentration was determined using the 
Bradford assay by mixing 1 mL dye with up to 10 µL of protein samples. BSA served as 
a standard. Alternately, ultra-violet absorbance of a protein solution measured at 280 nm 
was converted into protein concentration, based on the extinction coefficient calculated 
utilizing the ProtParam tool (ExPASy).    
Conventional tube-based MG/EK assay – Reagents for the malachite green 
assay were prepared according to Lanzetta et al. [40]. Briefly, 270 mg malachite green 
powder was dissolved in 600 mL deionized water (ddH2O), and mixed with 200 mL of an 
aqueous solution containing 8.4 g ammonium molybdate and 67 mL 12N HCl. This final 
mixture (MG reagent) was stirred for 1 h at room temperature and passed through 
Whatman No.5 filter paper before being stored at 4°C for future use. MG reagent (900 µL) 
was added to an eppendorf tube containing 100 µL of sample solution and allowed to 
react for 5 min for color development. The absorbance was measured at 660 nm.  
The three reagents used in the EK assay were prepared as previously reported [38, 
39]. Briefly, the ammonium molybdate (AM) solution was prepared by dissolving 2.5 g 
ammonium molybdate in 80 mL ddH2O, followed by addition of 13.6 mL 98% H2SO4. 
The volume was taken to 100 mL with ddH2O. The 0.5 M β-mercaptoethanol (β-ME) 
solution was prepared by diluting 350 µL β-ME to 10 mL with ddH2O. Both the AM and 
β-ME solutions were stored at 4°C. Finally, the eikonogen reagent was prepared by 
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dissolving 0.25 g of sodium sulfite, 14.65 g of meta-bisulfite, and 0.25 g of 1-amino-2-
naphthol-4-sulfonic acid in 100 mL ddH2O and stored in an amber bottle at room 
temperature. The eikonogen reagent was stirred and warmed on a hot plate each time 
before using to redissolve the salt crystals. To an eppendorf tube containing 380 µL of 
sample solutions was added 50 µL AM, 50 µL β-ME, and 20 µL eikonogen reagent 
sequentially. Color was developed by incubating the tube in a 37°C water bath for 10 min. 
The absorbance was measured at 580 nm.  
96-well plate format MG/EK combined assay – The MG assay reagent for the 
96-well plate assay is more concentrated than the MG reagent for the conventional tube-
based assay. First, 162 mg malachite green powder was dissolved in 180 mL ddH2O. 
Second, 5.04 g ammonium molybdate was mixed with 55 mL of 12N HCl and diluted to 
60 mL with ddH2O. These two solutions were mixed by stirring in a glass graduated 
cylinder for 1 h and filtered as described above. The MG reagent (200 µL) was added to 
each well of a 96-well plate containing 20 µL of sample. The plate was incubated at room 
temperature for 5 min and read at 655 nm.   
The plate-based EK assay reagents were prepared as described for the 
conventional tube-based EK assay. To 50 µL of the enzyme reaction mixture in an 
individual well of a 96-well reaction PCR plate was added sequentially 50 µL AM, 50 µL 
β-ME, and 20 µL eikonogen reagent. The mixture was incubated in a thermal cycler at 
37°C for 10 min and then transferred to a reading plate for absorbance measurement at 
540 nm. 
A standard 1 mM phosphate solution was prepared utilizing anhydrous NaH2PO4. 
A standard 1 mM pyrophosphate solution was prepared from NaP2O7·10H2O. Both 
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reagents were stored at 4°C. Serial dilutions of each standard were prepared to contain 0-
40 nmol Pi or PPi in 100 µL aqueous solution. These standards were divided into two 
separate portions (40 µL each), one for the malachite green assay and one for the 
eikonogen assay.  
The 96-well plate format determination of Pi and PPi in a mixture – From a 
100 µL sample containing both Pi and PPi, 20 µL was transferred for the MG assay and 
50 µL was transferred for the EK assay. The difference in sample size is due to the 
different sensitivities of the two assays. The concentration of Pi was directly determined 
from the MG assay according to equation 4-1. The concentration of PPi was solved from 
equation 4-2 using the Pi concentration calculated from equation 4-1. A655 was the 
absorbance reading of the MG assay and A540 was the absorbance reading of the EK assay. 
All extinction coefficients (ε) were determined from calibration curves.  
A655 = εPi-655·[Pi]                                   (4-1) 
A540 = εPi-540·[Pi] + εPPi-540·[PPi]                                    (4-2) 
Pyrophosphate assay – A commercial kit from the Sigma-Aldrich company was 
used to determine the PPi concentration in a mixture of Pi and PPi [41]. The kit consists of 
a series of enzymes that correlate the PPi concentration to the disappearance of the 
NADH signal at 340 nm. The result from this method was used to verify the accuracy of 
the PPi concentration measured by MG/EK method. Three mixtures of Pi and PPi at 
different ratios were prepared. A vial of lyophilized pyrophosphate reagent as supplied 
was reconstituted with ddH2O to 6 mL. To 50 µL of sample, 950 µL of pyrophosphate 
reagent solution was added and incubated at room temperature for 10 min. Absorbance 
readings at 340 nm were converted into concentration of NADH (ε = 6220 M-1cm-1) first 
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and next into concentration of PPi according to 1:1 stoichiometric ratio of NADH and PPi. 
The same samples were tested using the MG/EK assay. From each 100 µL sample, 20 µL 
was transferred for the MG assay and 50 µL was transferred for the EK assay. Pi and PPi 
concentrations were calculated as described above.  
Cloning, overexpression and purification of PpBC – The P. putida F1 cells 
were recovered by suspending approximately 50 mg of cell paste into 5 mL nutrient broth 
media, and incubating the mixture in a 37°C shaker overnight. A 200 µL aliquot from the 
overnight cell culture was spread on a nutrient broth agar plate and then incubated at 
37°C for 16 h. The Pput_3909 gene (gi148549115) was amplified by PCR using a single 
colony from the plate as the template. The forward primer was 
GATTCTAGAATTCATATGGCAAATTCTGAACAGCGGATTG, and the reverse 
primer was AATTCGGATCCAAGCTGCAGTCATTGCGCCATATTC. The PCR 
mixture contained 25 µL buffer K, 1 µL of each primers (OD260~15), the colony as a 
template, and sterile ddH2O up to 49 µL. After heating the reaction mixture at 95°C for 
2.5 min, 1 µL Vent DNA polymerase was added, followed by 30 cycles consisting of 
denaturation at 94°C for 1 min, annealing at 50°C for 1 min and extension at 72°C for 1.5 
min. After size verification by horizontal electrophoresis on 1% (w/v) agarose gel, the 
PCR product was digested with NdeI and BamHI. The expression vector pT7-LOH was 
similarly double digested and treated with calf intestinal alkaline phosphatase. The PCR 
product and the vector were ligated by T4 ligase at room temperature overnight. The 
ligation was transformed into chemically competent XL1-blue E. coli cells, which were 
then spread on an agar plate of LB supplemented with 100 mg/L ampicillin (LB/amp). A 
single colony containing the pT7-LOH-PpBC plasmid, verified by DNA sequencing, was 
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amplified and stored at -80°C in 25% glycerol. The pT7-7-PpBC plasmid was 
constructed in the same manner. 
The pT7-LOH-PpBC plasmid was transformed into chemically competent 
BL21(DE3) E. coli cells for expression. The cells were grown in 1 L LB/amp at 37°C 
with shaking at 230 rpm. Isopropyl-β-D-thiogalactoside (IPTG) was added to a final 
concentration of 0.2 mM when the cell culture reached OD600 of 0.5. The cells were 
allowed to grow at 17°C after induction for another 18 h, before being harvested by 
centrifugation at 6000 rpm in a Beckman JA-10 rotor for 10 min. The cell paste was 
resuspended in HisBind® (Novagen) binding buffer (20 mM Tris pH 8.0, 500 mM NaCl, 
5 mM imidazole), and sonicated in an ice-water bath for 30 s for 4 pulses, with 2 min 
intervals. The crude extract was then separated from the cell debris by centrifuging at 
29000 g for 20 min.  
The supernatant obtained from above (15 mL, 150 mg protein in total) was treated 
with 15 µL of DNase I and RNase A, each 10 mg/mL, at room temperature for 10 min. 
After filtration through a 0.22 µm Millex® membrane, the crude extract was mixed with 4 
mL HisBind® resin (Novagen) in a 50 mL centrifuge tube. The resin was saturated with 
his-tagged protein by rotating the mixture on Labquake® rotator (Barnstead International) 
at a low speed in 4°C overnight. The resin/protein mixture was then transferred in a Poly-
Prep® column (Bio-Rad) for washing, and eluted using column chromatographic 
techniques. The target protein was eluted in the binding buffer with 250 mM imidazole, 
and immediately dialyzed against 20 mM Tris pH 7.5. The resultant protein was 
homogenous as determined by SDS-PAGE with a total yield of 20 mg/liter of cell culture, 
and concentrated to 5.5 mg/mL before storage at -80°C.  
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Cloning, Overexpression, and Purification of PpB and PpC – A short 
nucleotide containing a stop codon and an NdeI site (TAAACATATG) was inserted into 
pT7-LOH-PpBC after the kdsB gene. The mutagenesis PCR was performed using pT7-
LOH-PpBC plasmid as the template, and the primer pair GCCTCTGACTTCATA 
AACATATGAAACCGAAACTGG and CCAGTTTCGGTTTCATATGTTTATGAAG 
TCAGAGGC. Pfu ultra DNA polymerase was used because of its high fidelity and 
efficiency in DNA replication. The PCR product was subjected to DpnI digestion at 37°C 
for 1 h to degrade the original template, and then transformed into XL1-blue E. coli cells 
for plasmid amplification. The plasmid obtained is designated pT7-LOH-PpB. Similarly, 
a pT7-7-PpB plasmid was also constructed based on pT7-7-PpBC. The pT7-7-PpB 
plasmid was digested by NdeI and self-ligated between two NdeI sites, one before the 
start codon and the other after the stop codon, resulting in the excision of PpB gene and 
formation of a pT7-PpC plasmid. All plasmids were sequenced.  
The pT7-LOH-PpB and pT7-PpC plasmids were each transformed into 
BL21(DE3) cells respectively for protein expression. Both PpB and PpC proteins were 
overexpressed the same way as described for PpBC. PpB bearing a his-tag was purified 
according to the same protocol as that of PpBC. A yield of 60 mg/L of cell culture was 
obtained. The homogenous PpB solution was concentrated to 7.1 mg/mL and stored at     
-80°C.  
Cells with overexpressed PpC were sonicated in buffer A (20 mM Tris pH 7.5). 
The clarified supernatant was applied to Q-sepharose equilibrated with buffer A. A linear 
gradient elution was performed from 0 to 2M KCl in 90 min. PpC was eluted in fractions 
containing approximately 0.4 M KCl, and verified by SDS-PAGE. The pooled fractions 
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were taken to 20% (w/v) ammonium sulfate by adding ammonium sulfate crystals before 
loading to a phenyl superpose column (HR 10/10). Protein was eluted using a reverse 
gradient from 20% to 0% (w/v) ammonium sulfate. The target protein was collected in 
fractions with around 3% ammonium sulfate. The pooled homogenous PpC was dialyzed 
against buffer A and concentrated to 3.6 mg/mL before stored at -80°C. The total yield 
was 30 mg/L of cell culture.   
pH dependence – Buffers used were sodium acetate pH 4-5, MES pH 5.5-6.5, 
HEPES pH 7-8, Tris pH 8.5-9.5, and glycine-NaOH pH 10-11.5 with pH values adjusted 
at 37ºC. All reaction mixtures contained 100 mM buffer, 5 mM MgCl2, substrate(s), and 
enzyme in a final volume of 50 µL. The reaction was initiated by adding 10 µL enzyme 
solution as will be specified, incubated at certain tmperature for certain amount of time as 
will be specified, and stopped by quenching with 50 µL 100% ice-cold ethanol. The 
phosphatase activity reactions catalyzed by PpBC and PpC were annotated as 
PpBC(KDO8P) and PpC(KDO8P), respectively. Specifically, the phosphatase assay 
included 0.8 mM KDO8P as the substrate and 5 µg PpBC or 7 µg PpC as the enzyme. 
The reactions were incubated at 37ºC for 1 min before quenching. The cytidyltransferase 
reactions catalyzed by PpBC and PpB were accordingly marked as PpBC(KDO/CTP) and 
PpB(KDO/CTP), respectively. Typically, two substrates, 0.8 mM KDO and 5 mM CTP, 
and 5 µg PpBC or 0.7 µg PpB were included. The reaction mixtures were incubated at 
50ºC for 5 min. The overall reaction is referred to as PpBC(KDO8P/CTP), with 0.8 mM 
KDO8P and 5 mM CTP supplied as substrates and 5 µg PpBC included. The reaction 
mixtures were also incubated at 50ºC for 5 min. Out of each 100 µL quenched reaction, 
20 µL was utilized for MG assay and 50 µL was transferred for EK assay. The amounts 
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of Pi and PPi were derived as described in the 96-well plate format determination of Pi 
and PPi. The signal was expressed as specific activity in unit/mg, which was defined as 
µmol of product (Pi or PPi) produced per minute per mg of enzyme.  
Temperature profile and thermostability – Each reaction included 100 mM 
glycine-NaOH pH 10, 5 mM MgCl2, 0.8 mM KDO8P or KDO, 5 mM CTP if needed, and 
enzyme as specified in the “pH dependence” section in a total volume of 50 µL. To 
measure temperature profile, reactions were carried out at a fixed temperature in the 
range of 20-90°C, with 10°C intervals. The quenched reaction mixtures were divided for 
color development as stated above. For thermostability measurements, enzymes were first 
incubated for 5 min at a single temperature ranging of 20-90°C (with 10°C intervals) and 
then added to pre-warmed reaction mixtures for 1 min incubation at 50°C.  
Substrate specificity – Various phosphosugars or aromatic compounds were used 
as substituent for KDO8P. Reactions were carried out with 100 mM glycine-NaOH pH 
10, 5 mM MgCl2, 0.8 mM of the corresponding substrate, 5 mM CTP, and 5 µg of PpBC 
in a total volume of 50 µL. After incubated at 50°C for 5 min, the reaction mixtures were 
quenched and analyzed as stated in the pH-dependence measurement section. 
Magnesium dependence – The Mg2+ dependence of the PpBC(KDO8P) activity 
was measured by mixing 100 mM glycine-NaOH pH buffer, 1 mM KDO8P, and 0-10 
mM Mg2+ and ddH2O up to 50 µL. The reaction mixtures were incubated at 50°C for 1 
min before subject to colorimetric assays. For PpBC(KDO/CTP) activity, the reaction 
mixtures contained 3 mM KDO, 5 mM CTP, and 0-20 mM Mg2+ at pH 10, and were 
incubated at 50°C for 5 min before analysis. 
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Metal analysis – The isolated PpBC, PpB and PpC proteins were treated with 10 
mM EDTA at 25°C for 2 h and then dialyzed against 20 mM Tris pH 7.5 for 24 h with 
two changes of buffer. The metal-depleted apo-enzymes were then treated with various 
divalent metal ions, including Mg2+, Mn2+, Co2+, Zn2+, Ba2+, Ni2+, Hg2+, Cd2+, and Ca2+, 
and assayed for activity. All reactions were carried out in 100 mM glycine-NaOH buffer 
at pH 10. The PpC was assayed with 0.8 mM KDO8P and 1 mM metal ion, and measured 
for Pi release. The PpB was supplemented with 0.8 mM KDO, 5 mM CTP and 5 mM 
metal ion, and measured for PPi release. The reaction mixture for the bifunctional enzyme 
PpBC included 0.8 mM KDO8P, 5 mM CTP and 5mM metal ion, and was measured for 
both Pi and PPi production. All buffers were made with Trizma, metal-free HCl and 
ddH2O.  
Kinetic measurements – Steady-state kinetics were measured under optimum 
conditions for each enzyme, with one substrate concentration varying at each time. The 
PpBC(KDO8P), PpC(KDO8P) were assayed at pH 10 with an incubation at 50°C for 1 
min. The PpBC(KDO/CTP), PpB(KDO/CTP) and PpBC(KDO8P/CTP) were assayed at 
pH 10 with an incubation at 50 °C for 5 min. Amounts of enzymes used were specified in 
the “pH dependence” section. The resultant saturation curves were fit nonlinearly to the 
Michaelis-Menten equation using Origin software to derive values of Vmax, KM and kcat. 
All data points are triplicates. 
Time course – The fusion enzyme PpBC was subjected to a time course 
measurement. A mixture of PpB and PpC at a 1:1 molarity ratio was also measured for 
time dependence. The reactions contained 100 mM Na-glycine pH 10, 5 mM MgCl2, 5 
mM CTP, 0.8 mM KDO8P, and 10 µL enzyme solution containing 3 µg of PpBC or 
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PpB/PpC in the mixture. Each 50 µL reaction was initiated by the addition of enzyme 
solution, and incubated at 50 °C. The reactions were quenched after 1, 2, 5, 10, 20, 30, 40 
and 60 min, and divided for separate MG and EK color development.  
 
4.4 Results 
Assay development – A combination of malachite green and eikonogen (MG/EK) 
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Figure 4-6 Calibration curves of the malachite green assay and eikonogen assay in the 
conventional tube-based format. For a mixture of Pi and PPi, total eikonogen signal is the 
sum of both Pi and PPi signal, shown as a hypothetic line in the eikonogen assay plot.  
 
Calibration curves of MG/EK were first obtained in a conventional tube-based 
format. Samples of Pi and PPi were prepared in a range between 0-40 nmol in a volume 
of 100 µL, and equally divided for the MG and EK assays. All data points were measured 
in triplicate. Linear curves were observed for all calibrations (Figure 4-6). In the MG 
calibration curve, PPi showed negligible absorbance at 660 nm, whereas in the EK assay 
both Pi and PPi exhibit measurable signals. The slope of each curve was derived from a 
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linear fit equation and converted to an extinction coefficient with units of M-1cm-1. The 
extinction coefficients are listed in Table 4-4. 
 
Table 4-4 Extinction coefficients (ε) of Pi and PPi for the MG or EK assay. 
 
  εPi (M-1cm-1) εPPi (M-1cm-1) 
MG 660 nm 2760 2 
Tube-based 
EK 580 nm 765 3225 
  εPi (M-1) εPPi (M-1) 
MG 655 nm 6700 44 
96-well plate 
EK 540 nm 880 3470 
 
Assays were also carried out in a 96-well plate format to more easily include 
systematic controls and to create a format for future high throughput screening. 
Calibration curves of the MG and EK assays in a 96-well plate format were obtained. 
Individual samples of Pi and PPi were prepared at concentrations between 0-0.4 mM, and 
each divided equally for the MG (40 µL) and EK (40 µL) assays. All data points were 
collected in triplicate. Linear curves obtained followed the same pattern as measured with 
the conventional tube-based method (Figure 4-7). Extinction coefficients are reported in 
M-1 units because the light path in the absorbance measurement differs with sample 
volume in the wells (Table 4-4). Since the MG is two-fold more sensitive than EK assay 
in 96-well plate measurements (εPi-655 ≈ 2εPPi-540), the reaction mixtures to be analyzed 
were divided unevenly in measurements: typically 20 µL for MG and 50 µL for EK from 
every 100 µL total reaction mixture. The extinction coefficient was calculated from a 
four-point standard curve on each plate to reduce error from buffer absorbance, plate 
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Figure 4-7 Calibration curves of malachite green assay and eikonogen assay in the 96-
well plate format. For a mixture of Pi and PPi, total eikonogen signal is the sum of both Pi 
and PPi signal, shown as a hypothetic line in the eikonogen assay plot. 
 
The determination of Pi and PPi concentrations in a mixture is illustrated in 
Figure 4-8. A binary mixture of Pi and PPi at 1:1 was prepared and serially diluted to 
samples containing 0-0.2 mM Pi and PPi each. The absorbance is linearly correlated to 
sample concentrations. Since the MG absorbance reading is only contributed by Pi 
(Figure 4-8a), the concentration of Pi can be directly calculated from the MG signal 
using an extinction coefficient deduced from a standard curve (Figure 4-8b). The total 
EK absorbance reading contributed by both Pi and PPi is supposed to be a linear 
combination of Pi and PPi concentrations, each weighted by an extinction coefficient 
(Figure 4-8c). With the amount of Pi determined from the MG assay, the portion of the 
EK signal derived from the PPi can be deduced by subtracting the absorbance due to the 
Pi from the total EK signal. Finally, the amount of PPi can be calculated from this portion 
of the EK signal contributed by PPi alone (Figure 4-8d). The amounts of Pi and PPi in 50 
µL volume determined from the experimental data match well with the theoretically 
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Figure 4-8 Determination of Pi and PPi amounts from a binary mixture at a ratio of 1:1. a) 
The MG signal of the binary mixture. b) The Pi amount determined from the MG signal. 
c) The total EK signal of the binary mixture shown in black line; the EK signal of Pi 
shown in blue, built upon Pi amount determined in b); and the EK signal of PPi shown in 
red, calculated by subtracting the blue line from the black line. d) The PPi amount 
determined from the red line in c).  
 
 
The accuracy of the PPi measurement was further confirmed using a 
commercially available pyrophosphate reagent kit from Sigma. This kit detects PPi 
generated from the reaction mixture by reacting the PPi with fructose 6-phosphate 
catalyzed by PPi-fructose-6-phosphate kinase. The resultant fructose-1,6-diphosphate is 
further converted to dihydroxyacetone phosphate through two enzymatic reactions 
catalyzed by aldolase and triosephosphate isomerase. Finally, the reduction of 
95 
dihydroxyacetone phosphate is coupled to the conversion from NADH to NAD+, causing 
a decrease of NADH signal at 340 nm. All the coupling enzymes mentioned above and 
substrates except PPi are included in the pyrophosphate reagent as supplied. Samples with 
random amount of Pi and PPi were “blindly” prepared and subjected to both the MG/EK 
coupled assay and the Sigma pyrophosphate assay kit. Results listed in Table 4-5 show 
that these two methods agree on pyrophosphate detection with only small errors, and are 
both close to the true values. These results indicate that the coupled MG/EK assay is an 
accurate and reliable method for Pi and PPi measurement. 
 
Table 4-5 Comparison of the Sigma pyrophosphate reagent to the coupled MG/EK assay. 
Data from MG/EK methods are the average of duplicate measurements. Percentages in 
parentheses are errors of the experimental values compared to the true values (shown as 
“Added” in the table). 
 
   Sample Added (nmol) 
Pyrophosphate 
Reagent (nmol) MG/EK (nmol) 
PPi 35 33.1 (5.4%) 34.13 ± 0.05 (2.5%) 
A 
Pi  20  20.36 ± 0.65 (1.8%) 
PPi 10 9.9 (1.0%) 10.54 ± 0.68 (5.3%) 
B 
Pi  45  39.94 ± 0.31 (11.2%) 
PPi 45 42.1 (6.4%) 43.46 ± 0.37 (3.4%) 
C 






P._putida (1)        MANSEQRIAIVIPARFGSTRLPGKPLADIAGKPMVQHVYERALQVKNAQCVVIATDDERVANAV 64 
N._meningitidis      MNTENLKTVIVVPARYASTRLPGKPLADICGKPMIQHVYERACKVPYIDDVIVAVDDRRVAEVV 64 
H._influenzae        -----MSFTVIIPARFASSRLPGKPLADIKGKPMIQHVFEKALQSG-ASRVIIATDNENVADVA 58 
E._coli              -----MSFVVIIPARYASTRLPGKPLVDINGKPMIVHVLERARESG-AERIIVATDHEDVARAV 58 
Y._pestis            -----MSFIAIIPARYASTRLPGKPLADIAGKPMVVHVMERALASG-ADRVIVATDHPDVVKAV 58 
P._putida (2)        ---MSLEFTVVIPARLRSTRLPGKPLLLIAGKPMVQHVWEQARKSG-ASRVVIATDDTSILEAC 60 
H._pylori            --------MIIIPARLKSSRFENKVLEDIFGLPMVVRCAKNANLVD---ECVVACDDESIMQTC 53 
A._aeolicus          -----MRRAVIIPARLGSTRLKEKPLKNLLGKPLIRWVVEGLVKTG--ERVILATDSERVKEVV 57 
                           ::***  *:*:  * *  : * *::    :           ::* *   :  . 
 
P._putida (1)        RDFGGEYVMTSPDHPSGTDRLAEVMAQV---DADIYINLQGDEPLVRPGDIETLATGMLADHDV 125 
N._meningitidis      ESFGGKVIMTSTQHDSGTDRLVEVMGKY---AADIYINIQGDEPLIRSEDIALLAQGMK-DEQI 125 
H._influenzae        KSFGAEVCMTSVNHNSGTERLAEVVEKLAIPDNEIIVNIQGDEPLIPPVIVRQVADNLAKF-NV 122 
E._coli              EAAGGEVCMTRADHQSGTERLAEVVEKCAFSDDTVIVNVQGDEPMIPATIIRQVADNLAQR-QV 122 
Y._pestis            EAAGGEVCLTRADHQSGTERLAEVIEHYGFADDDIIVNVQGDEPLVPPVIIRQVADNLAAC-SA 122 
P._putida (2)        QAFGAEVLMTRADHESGTDRLAEVAAYLGLPADAIVVNVQGDEPLIPPVIIDQVAANLAAHPEA 124 
H._pylori            QKFHIKAVLTSKHHNSGTERCLEAARILGLKNDERVLNLQGDEPFLEKEVILALLEATKN---A 117 
A._aeolicus          EDL-CEVFLTPSDLPSGSDRVLYVVRDL---DVDLIINYQGDEPFVYEEDIKLIFRELEKG--E 117 
        .    :  :*  .  **::*   .            :* *****::    :  : 
 
P._putida (1)        SVGTLCHLID-TEEAVNPNTVKVVLAENGNALYFSRSPIPYPRD-----------SQTATYLKH 180 
N._meningitidis      SVGTLCHALP-ASEATNPNTVKVVLSANGNALYFSRSPIPYPRD-----------KEHAYYFKH 179 
H._influenzae        NMASLAVKIHDAEELFNPNAVKVLTDKDGYVLYFSRSVIPYDRDQFMNLQDVQKVQLSDAYLRH 185 
E._coli              GMATLAVPIHNAEEAFNPNAVKVVLDAEGYALYFSRATIPWDRDRFAK----DLETVGDNFLRH 181 
Y._pestis            GMATLAVPIASSEEAFNPNAVKVVMDAQGYALYFSRATIPWERERFAQ----SKETIGDCFLRH 181 
P._putida (2)        GIATLAEPIHEPETVFNPNAVKVVSDKNGLALTFSRAPLPWARDTFAKAR--DVLPEGVPYRRH 186 
H._pylori            PFMATCAKVIDEEQAKSPNLVKVVLDSQNNALYFSRSLIPFLRD--------FDAKRQTPLLGH 170 
A._aeolicus          RVVTLAR--KDKEAYERPEDVKVVLDREGYALYFSRSPIPYFRK-----------NDTFYPLKH 169 
                  . : .      .    *: ***:   :. .* ***: :*: *.                   * 
 
P._putida (1)        VGVYAYR-RAVLSEYSRLPQPMIEHTEKLEQLRLLAAGYSIRAYRVEPT-GPGVDTPECLEKVR 240 
N._meningitidis      IGVYAYR-KETLAKYSNLKQPDIELSEKLEQLRLLDAGIDIRVFEVPET-GPGVDTPECLERVR 239 
H._influenzae        IGIYAYR-AGFIKQYVQWAPTQLENLEKLEQLRVLYNGERIHVELAKEVPAVGVDTAEDLEKVR 248 
E._coli              LGIYGYR-AGFIRRYVTWQPSPLEHIEILEQLRVLWYGEKIHVAVAQEVPGTGVDTPEDLKRVR 244 
Y._pestis            IGIYAYR-AGFIRRYVNWAPSQLEQIELLEQLRVLWYGEKIHVAVAKAVPAVGVDTQSDLDRVR 244 
P._putida (2)        IGMYAYR-VGFLHDFVSWGPCWLEQAEALEQLRALWHGVRIHIEDAIEAPAVGVDTPEDLERVR 259 
H._pylori            IGIYGFHNKEILEELCALKPCVLEEIEKLEQLRALYYQKKIAVKIVQSE-SVGIDTQEDLQNAL 234 
A._aeolicus          VGIYGFR-KETLMEFGAMPPSKLEQIEGLEQLRLLENGIKIKVLITENY-YHGVDTEEDLKIVE 229 
                :*:*.::    :          :*  * ***** *     *    .      *:** . *. . 
 
P._putida (1)        ALIAGQPLTSKP--KLADIRLVITDVDGVLTDGGIYYDSTGECLKRFHVRDGMGMRLLEENGVR 301 
N._meningitidis      AIMSGQLPIDKHSVNLADIRLVITDVDGVLTDGGIFYNENGECLKRFHVRDGLGIRLLEESGIK 302 
H._influenzae        AILAAN      4 KLENIKFVITDVDGVLTDGQLHYDANGEAIKSFHVRDGLGIKMLMDAGIQ 53 
E._coli              AEMR       22 KAENIRLLILDVDGVLSDGLIYMGNNGEELKAFNVRDGYGIRCALTSDIE 71 
Y._pestis            AIMLNQ     21 RAANIRLLICDVDGVMSDGLIYMGNQGEELKAFNVRDGYGIRCLITSDID 70 
P._putida (2)        RLLEA       8 RGKGIKLAVFDVDGVLTDGRLYFLEDGSEFKTFNTLDGQGIKMLMASGVT 57 
H._pylori            KIFSPDLLER       MIKLLLLDVDGTLTDGSLYFDENFHEIKAFNVKDGLGMTLWQKLGKK 47 
A._aeolicus          EKLKNL      6 RVKKLKLLIMDIDGVLTDGKLYYTEHGETIKVFNVLDGIGIKLLQKMGIT 55 
                  :               ::: : *:**.::** ::       :* *:. ** *:      . 
 
P._putida (1)        VAVLSGRDSATLRKRVTDLGITLHQFGVKDKLKACNQLMEEAGVTAEQTACIGDDCIDLPAFSA 365 
N._meningitidis      VAVLSGRDSPTLRKRIDDLGISYYQLGIKDKHAACIELMQEANCLKEQTAYIGDDTIDLPAFSA 366 
H._influenzae        VAVLSGRDSPILRRRIADLGIKLFFLGKLEKETACFDLMKQAGVTADQTAYIGDDSVDLPAFAV 117 
E._coli              VAIITGRKAKLVEDRCATLGITHLYQGQSNKLIAFSDLLEKLAIAPENVAYVGDDLIDWPVMEK 135 
Y._pestis            VAIITGRRAKLLEDRANTLGITHLYQGQSDKLVAYHELLATLQCQPEQVAYIGDDLIDWPVMAQ 134 
P._putida (2)        TAIISGRKTPVVERRASNLGIPHLYQGREDKLVVLDGLLAELGLSYDQVAYLGDDLPDLPVIRR 121 
H._pylori            IAIITGRTSIMVKKRMESLGVQFVFMGVENKNTVIERLKKDLQLSAQEIACVGDDYNDLGMFKA 111 
A._aeolicus          LAVISGRDSAPLITRLKELGVEEIYTGSYKKLEIYEKIKEKYSLKDEEIGFIGDDVVDIEVMKK 119 
                *:::** :  :  *   **:     *  .*      :        :: . :***  *   : 
 
P._putida (1)        CGISFAVADAPVYVKAAATETLLAMGGTGAFREVADAILCAQGKSAVLLTAAGYAQVMANMAQ 428 
N._meningitidis      CGLSFAVADTPEYIRNQADITLTLPGGYGAFRELADKILAAQGKEDVFSSEAGFAQVMHGANQ 429 
H._influenzae        CGASFAVADAPIYVKNTVDHVLSTNGGKGAFREMSDMILQAQGKSSVFDTAQGFLKSVKNMGQ 180 
E._coli              VGLSVAVADAHPLLIPRADYVTRIAGGRGAVREVCDLLLLAQGKLDEAKGQSI---------- 188 
Y._pestis            VGLSVAVADAHPLLLPKAHYVTRIKGGRGAVREVCDLILLAQDKLEGATGLSI---------- 187 
P._putida (2)        VALGMAVANAAPFVRQHAHGVTQARGGEGAAREFCELIMQAQGTLDTANANYL---------- 174 
H._pylori            CALSFAPFDAHPLLKSKAYKVLQNSGGKGAVREAIDYLLTLEGLQDEALKLYL---------- 164 
A._aeolicus          VGFPVAVRNAVEEVRKVAVYITQRNGGEGALREVAELIHFLKND------------------- 163 
                                 .  .*  ::   :   .       ** ** **  : :   :. 
* fully conserved residue  : conservation of strong groups  . conservation of weak groups 
 
 
Figure 4-9 Sequence alignment of two bifunctional enzymes (the first two entries) and 
several individual KdsCs (conservative residues showing in red background) and KdsBs 
(conservative residues showing in blue background) from G- bacteria strains by ClustalW. 
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Preparation of PpBC, PpB and PpC – Based on the sequence alignment with 
known KdsBs and KdsCs (Figure 4-9), we should be able to divide PpBC into two 
individually active peptides, PpB and PpC. The division site chosen was between Pro152 
and Lys153 to allow the integrity of each part and to hopefully avoid secondary structure 
interruption in each resultant peptide.  
The pT7-LOH-PpBC plasmid was constructed and transformed into E. coli 
BL21(DE3) for expression. The resulting recombinant protein was purified using a Ni-
NTA affinity column and resulted in a yield of 20 mg/L of cell culture. The pT7-LOH-
PpB and pT7-7-PpC plasmids were also constructed and transformed into E. coli 
BL21(DE3) for expression. The his-tagged PpB was purified with a Ni-NTA column and 
a yield of 60 mg/L of cell culture was achieved. PpC was purified using a combination of 
a Q-sepharose anion exchange column followed by a phenyl superose column. The final 
yield of PpC was 30 mg/L of cell culture. The homogeneity of the proteins was verified 
by SDS-PAGE (Figure 4-10). The observed molecular weights are 52 kDa for PpBC, 32 
kDa for PpB, and 23 kDa for PpC, which are all slightly higher than the calculated 
molecular weight from the amino acid sequence. 
 
 
    
Figure 4-10 SDS-PAGE of purified PpBC, PpB and PpC. 
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pH dependence – The phosphatase activity was measured at pH 4-11 for PpBC, 
PpC and E. coli KdsC (KdsCEc) using KDO8P as the only substrate (Figure 4-11a). The 
amount of Pi released for each reaction after 1-min incubation was quantified by the MG 
assay. The relative activity was calculated by dividing the specific activity at each pH by 
the activity at the optimum pH. The pH dependent curves for PpBC and PpC almost 
overlap. The pH dependent curve of KdsCEc measured in this study has an identical shape 
to that reported by Wu and Woodard [42]. All pH dependence curves are bell-shaped and 
peak around pH 6. Although all these enzymes favor an acidic pH, PpBC and PpC seem 
to have a broader pH adaption, spanning pH 5-8, than does the KdsCEc. Especially at pH 
10, PpBC and PpC retain 60% of the optimum activity, while KdsCEc only retains 10%.  
The cytidylyltransferase activity was measured for PpB with KDO and CTP as 
substrates by monitoring the amount of PPi released after a 5-min incubation. PpB 
reaches a maximum activity at pH 10, which agrees with the previously reported pH 9.5 
value for both the E. coli KdsB (KdsBEc) [43] and a maize KdsB homologue [44]. The 
complete pH dependence curve, reported the first time, shows that the enzyme is only 
active at an alkaline pH.  
Finally, the combined activities were measured for PpBC (KDO8P/CTP). 
Coupled MG/EK was used to determine both Pi and PPi for 5-min enzyme reactions. The 
overall specific activity is represented by the unit time production of PPi. The pH 
dependence curve of PpBC almost overlaps with that of PpB, and also reaches a 
maximum activity at pH 10. However, the coupled activity for of the phosphatase and the 
cytidylyltransferase retains only 10% at pH 7, which is the optimum pH for PpC. The 
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KDO8P was incubated at pH 10 for 5 min and measured for free Pi, and no chemical 









































Figure 4-11 The pH dependence of KdsC and KdsB activities. a) E. coli KdsC (labeled 
as EcC), PpBC and PpC were assayed with KDO8P as substrate and activities were 
measured as Pi release. b) PpBC was assayed with KDO8P and CTP as substrates, and 
PpB was assayed with KDO and CTP as substrates. Both reactions are measured for PPi 
release. 
 
Temperature profile and thermostability – Both phosphatase and 
cytidylyltransferase activities were measured at various temperatures. Although the living 
environment of P. putida F1 is at ambient temperature, both activities favor high 
temperatures (>50°C). The phosphatase activity assayed with PpBC utilizing KDO8P as 
a substrate is high between 50-80°C. The cytidylyltransferase activity measured with PpB 
utilizing KDO and CTP as substrates reaches a maximum at 50°C. In order to maximize 
both activities, the temperature of the coupled enzymatic reaction was chosen to be 50°C. 
To investigate the thermostability of the enzymes, PpBC was incubated at various 
temperatures for 5 min and then assayed at 50°C. The enzyme activity is stable below 
70°C, suggesting a good thermostability.  
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When assaying the enzymes at high temperatures such as 50°C, CTP and KDO8P 
may degrade to generate Pi and/or PPi thus interfering with the determination of the Pi 
and PPi released from the reaction mixture. Control wells containing only CTP or 
KDO8P were therefore included in the 96-well plates. Absorbance readings generated by 
CTP or KDO8P were subtracted from the enzymatic reaction mixture. CTP generated 



















































Figure 4-12 a) Temperature profiles of PpBC and PpB. PpBC was measured for Pi 
release with KDO8P as the only substrate, whereas PpB was measured for PPi release 
with KDO and CTP as substrates. b) Thermostability of PpBC, measured for PPi release 
with KDO8P and CTP as substrates.  
 
Substrate specificity – In the coupled reaction of PpBC, KDO8P was substituted 
by substrate analogs, mostly phosphosugars. Each reaction mixture contained enzyme, 
0.8 mM KDO8P or analog, 5 mM CTP, 5 mM magnesium ion, and 100 mM glycine-
NaOH buffer at pH 10 and was incubated at 50 °C for 5 min. Pi and PPi were measured 
by the MG/EK assay. Not surprisingly, all compounds except KDO8P and KDO release 
little Pi and negligible PPi, which is consistent with the previously reported results for 
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KdsCEc [42], suggesting that PpBC has a high substrate specificity for the first enzymatic 
step, the phosphatase reaction. Besides utilizing the KDO8P/CTP pair as substrates for 
the first enzymatic reaction and producing KDO for the next step, PpBC can also uptake 
KDO directly from the buffer for the second enzymatic reaction. The specific activity for 
KDO/CTP is determined to be slightly higher than KDO8P/CTP (1.00 vs. 0.60  
µmol·min-1·mg-1), possibly due to the incompletion of the first step. Stated differently, 
KDO8P is not 100% converted into KDO when processed by the phosphatase active site 
of PpBC. Excluding this lagging effect, the specific activities of these two reactions 
appear to be very close to each other. 
 
Table 4-6 Substrate specificity of PpBC. 
Compound  Pi production  µmol·min-1·mg-1 
PPi production  
µmol·min-1·mg-1 
KDO8P  1.34 0.60 
KDO  <0.01 1.00 
p-Nitrophenylphosphate  0.19 <0.01 
D-Ribose 5-phosphate  0.17 <0.01 
Phosphoenolpyruvate  0.13 <0.01 
D -Arabinose 5-phosphate 0.12 <0.01 
D -Glucose 6-phosphate  0.12 <0.01 
D -Mannose 6-phosphate  0.12 <0.01 
D -Erythrose 4-phosphate  <0.01 <0.01 
 
 
Metal requirement – All previously reported KdsCEc [42] and KdsBEc [43] 
require Mg2+ for activity. For the fusion protein activities, PpBC(KDO8P) representing 
102 
the KdsC activity is Mg2+ dependent and PpB(KDO/CTP) representing the KdsB activity 
requires Mg2+ to function (Figure 4-13). Reaction mixtures omitting MgCl2 served as 
blanks. KdsC activity is very sensitive to metal ion concentration. It reaches maximum 
activity at 0.1 mM Mg2+, and only drops to 60% at 10 mM. However, the KdsB activity 
is less sensitive to the metal ion and reaches a plateau above 5 mM Mg2+. Based on these 























Figure 4-13 Magnesium dependence of PpB and PpBC. PpB was assayed for PPi release 
with KDO and CTP as substrate, whereas PpBC was assayed for Pi release with KDO8P 
as the only substrate. 
 
Other metal ions were also tested. According to the activity assay results of 
PpC(KDO8P), PpB(KDO/CTP), and PpBC(KDO8P/CTP) supplemented with various 
metal ions (Figure 4-14), Mn2+-assisted reactions also produce significant amounts of Pi 
and PPi, suggesting Mn2+ as an alternate metal cofactor. The Co2+ ion is a weaker 
cofactor for the KdsC activity based on the observable Pi release, but not a cofactor for 
the KdsB activity. These results are again consistent with previous reports for E. coli 
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enzymes [42, 43], and prove Mg2+ to be the best cofactor tested. Due to the unbeatable 
high activities in the presence of Mg2+, this metal ion is possibly the physiological metal 






































































Figure 4-14 Metal requirement of a) PpC, measured for Pi release with KDO8P as 
substrate, b) PpB, measured for PPi release with KDO and CTP as substrates, and c) 
PpBC, measured for PPi release with KDO8P and CTP as substrates. 
 
 
Steady-state kinetics – Saturation curves were obtained from each enzyme assay 
by varying the concentration of one substrate and fixing the concentration of the other. 
All the curves were fit nonlinearly to the Michaelis-Menten equation using Origin 




































δ                                                                (4-3) 
Errors for kcat/KM were calculated according to error propagation (Equation 4-3). 
The phosphatase activities represented by PpC(KDO8P) and PpBC(KDO8P) are 
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compared in the top panel of the table. When supplemented with KDO8P in the absence 
of CTP, PpBC displays only the phosphatase activity and cannot process the cytidylyl 
transfer reaction. PpC, as a truncated KdsC domain from PpBC, has a similar affinity for 
KDO8P (KM) but a 2-fold higher catalytic efficiency (kcat) compared to ppBC, suggesting 
that the substrate binding event of KdsC domain in the fusion protein is not affected by 
the covalently linked KdsB domain, but the catalytic turnover is somehow assisted by the 
KdsB domain. The slightly higher KM and 2-fold lower kcat make PpC a KdsC 3-fold less 
efficient than PpBC (kcat/KM). Overall, the KdsC activity in the fusion protein is weaker 
than KdsCEc (Table 3-2, KM = 71 µM, kcat = 456 s-1), with a 30-fold increase in KM and a 
30-fold drop in kcat.   
 
Table 4-7 Steady state kinetic parameter measurements of PpBC, PpC, PpB. Data in the 
top section were measured for Pi release with KDO8P as the only substrate; data in the 
middle section were measured for PPi release with KDO and CTP as substrates; data in 
the bottom section were also measured for PPi release but with KDO8P and CTP as 
substrates. Apparent KM values are reported. 
 
 KM 






kcat/KMKDO8P or KDO 
(mM-1s-1) 
PpBC KDO8P 2.1 ± 0.3 -- 18 ± 2 8.3  ± 1.5 
PpC KDO8P  2.4 ± 0.4 -- 6.4 ± 0.6 2.7  ± 0.5 
PpBC KDO/CTP 0.78 ± 0.06 0.67 ± 0.09 2.5 ± 0.1 3.3  ± 0.3 
PpB KDO/CTP 1.7 ± 0.1 0.69 ± 0.01 13.7 ± 0.2 8.2  ± 0.7 




When supplementing KDO and CTP in the reaction mixture, PpBC displays only 
the cytidylyltransferase activity. The middle panel in Table 4-7 lists the measured 
parameters of KdsB activities represented by PpB(KDO/CTP) and PpBC(KDO/CTP). 
The separate KdsB domain, PpB, behaves quite differently than the full-length enzyme 
by displaying a catalytic rate (kcat) about 5-fold higher and an affinity for KDO (KMKDO) 
2-fold lower. Comparing the CMP-KDO synthetase activity in P. putida F1 to E. coli 
enzymes, the KM for KDO of PpBC and PpB is on the same order of magnitude to that 
reported for K-CKS (KpsUEc) [16], but 10-time higher than for L-CKS (KdsBEc) [43]. 
Both PpB and PpBC show a similar affinity for CTP, indicating a relative independent 
behavior of CTP binding.  
The overall activity of PpBC (KDO8P/CTP) is quite comparable to PpBC 
(KDO/CTP) in both KM and kcat. This information points out that the KdsB activity in the 
fusion protein is the rate-limiting step. This bifunctional enzyme can utilize both KDO 
and KDO8P to produce the activated CMP-KDO in similar rates. 
Time course – PpBC was mixed with KDO8P and CTP, and measured for Pi or 
PPi release after 1, 2, 5, 10, 20, 30, 40, 60 min incubation.  Pi builds up within one minute 
in the coupled reaction catalyzed by PpBC, while PPi accumulates slower and reaches the 
maximum in 30 min (Figure 4-15). These results agree with the steady-state kinetic 
measurements which reveal that the CMP-KDO synthetase activity is the rate-limiting 
step in the fusion enzyme (Table 4-7 PpBCKDO8P and PpBCKDO8P/CTP). The mixture of 
PpC/PpB was also measured for time course and compared to the covalently linked 
bifunctional enzyme. The indistinguishable rates of Pi and PPi formation in the PpB/PpC 
catalyzed reactions suggest that the KDO produced from PpC is further consumed by 
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PpB immediately. This fact is coincident with the prediction based on the steady-state 
kinetic parameters (Table 4-7 PpCKDO8P and PpBKDO/CTP), which indicates that PpC is the 
rate-limiting activity in this enzyme pair. Overall, PpBC is more efficient than the 
PpC/PpB pair in converting KDO8P into CMP-KDO.  
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Assay of Pi and PPi – A combined colorimetric assay was developed capable of 
measuring both Pi and PPi simultaneously and independently. Decent sensitivities for Pi 
and PPi detection are achieved, each in the range of 0-0.4 mM, as suggested by the linear 
calibration curves. In a mixture of Pi and PPi, the amount of Pi is directly derived from 
the malachite green signal. In contrast, absorbance of the eikonogen assay comprises 
signals of two chromophores which are formed independently by Pi and PPi.  Since the Pi 
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amount is solved from the MG signal, PPi can be calculated by subtracting the Pi 
contribution from the total EK signal. Both assay reagents contain strong acid that results 
in a low pH in the detection mixture, and have the colors develop in the same time scale 
(minute range), therefore allowing the sample solutions for different assays being 
maintained in the same chemical environment. Only when the samples subjected to MG 
and EK assays are identical can the Pi amount determined from MG be used in the 
deconvolution of EK signals. The accuracy of PPi measurement was confirmed by the 
pyrophosphate reagent assay from Sigma. Unlike other reported pyrophosphate 
determination assays, the combined MG/EK assay does not introduce any Pi source into 
the reaction mixture, and therefore can monitor the Pi purely produced by the target 
reaction. Although PPi is the final product, it is interesting to follow the product of the 
first enzymatic reaction, Pi, at the same time. The combination of two colorimetric assays 
reduces complexity by avoiding using coupled enzyme, and has a relatively low cost by 
utilizing only commercially available chemicals.  
The simplicity of this method enables the application of a 96-well plate format. 
After quenching with one volume of 100% ethanol, the reaction mixture on a reaction 
plate was immediately divided into two portions and subjected to MG and EK 
respectively, providing exactly the same sample volumes for both detection methods. The 
uneven division of a reaction mixture, 20 µL for MG and 50 µL for EK, is to achieve 
relatively the same level of absorbance in both assays, since the extinction coefficients 
differs about 2-fold. Using the 96-well plate format, systematic blanks can easily be set 
up for each test. For example, CTP self-degradation in acid can be subtracted from the 
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reaction by setting up various amounts of CTP in the reference wells. This method can be 
extended to any coupled reactions generating Pi and PPi as products, 
PpBC is a bifunctional enzyme – The putative bifunctional enzyme PpBC was 
first discovered at the primary structural level from a conserved domain BLAST search 
of the NCBI database utilizing KdsCEc as the probe. The sequence alignment (Figure 4-9) 
reveals that the N-terminal amino acids 1-252 share many conserved residues with KdsBs, 
especially those residues proposed to be involved in Mg2+ coordination (D106, D246), 
CTP binding (R15, S18, T19, R20, K24, R84) and KDO binding (R164, H192, Y196, 
E221, Q222)[45, 46]. Meanwhile, residues 253-428 in the C-terminal part show KdsC 
characteristics including not only the conservation of all the haloacid dehalogenase 
superfamily (HADSF) motifs (discussed in Chapter 1), but also the presence of the KdsC-
specific signature sequence GGxGAxRE[42]. The sequence conservation explicitly 
divides PpBC into two parts.  Each part should hopefully fold as an individual domain, 
and function as a KdsB (i.e. CMP-KDO synthetase or CKS) for the N-terminal part and a 
KdsC (i.e. KDO8P phosphatase) for the C-terminal part. Based on this prediction, the 
fusion enzyme was divided to two putative monofunctional peptide domains, which are 
individually cloned and expressed as PpB and PpC. The resultant soluble PpB and PpC 
display the expected activities, and are similar to their previously reported counterparts 
from other microorganisms in terms of metal requirement (Figure 4-13, 4-14) and 
substrate specificity (Table 4-5). All these facts prove that the division of the PpBC does 
result in two separate monofunctional enzymes. The full-length fusion protein was also 
prepared as a soluble protein, and tested for both separate activities as well as combined 
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activity. When incubated with KDO8P and CTP, PpBC released both Pi and PPi, 
indicating that it is indeed a bifunctional enzyme. 
The CKS activity – When provided with KDO and CTP, PpBC solely displays 
CKS activity. The KM values for KDO and CTP measured for PpBC are in the mM range, 
which is on the same order as the reported KM for K-CKS (KpsUEc) [16], but 10-fold 
higher than that reported for L-CKS (KdsBEc) [43], further confirming that the activating 
activity is most like the K-CKS. Compared to the individual CKS domain, PpB (1.67 
mM), ppBC has a 2-fold lower KM for KDO (0.78 mM). On the other hand, PpBC 
(KDO/CTP) shows a kcat on the same order of magnitude as that of K-CKS [16], 10-fold 
lower than PpB, and 100-fold lower than the reported L-CKS [43]. This difference 
between PpBC (KDO/CTP) and PpB is possibly related to the ability of dimer formation. 
A dimeric structure for both K-CKS [45] and L-CKS [47, 48] has been previously 
reported, however no mechanistic significance of dimerization was reported. PpBC may 
not be able to form a dimer in the presence of the covalently linked KDO8P phosphatase 
domains.  
The 10-fold lower catalytic rate of the CKS activity, compared to the phosphatase 
activity (kcat = 1.65 vs. 17.7 s-1), indicates that CKS is the rate limiting step in this fusion 
enzyme, therefore the CKS activity should dominate the overall coupled activity of PpBC 
in kinetic properties. Based on this conclusion, it is not surprising that PpBC (KDO/CTP) 
and PpBC (KDO8P/CTP) have comparable catalytic rates (kcat = 1.65 vs. 0.9 s-1). In fact, 
the CKS activity is limiting the overall coupled activity at all tested pH values, since the 
pH dependence curves of PpB and PpBC(KDO8P/CTP) are almost overlapping (Figure 
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4-11b). Consistent with these result is the fact that KdsB has been previously reported to 
be the rate limiting step in the overall LPS biosynthesis [43].  
The phosphatase activity – The KM values for KDO8P of the phosphatase 
activities appears to be not affected by the covalently linked CKS domain, since the 
values are quite close for both PpBC and PpC (Table 4-6). In addition, activities of the 
fused phosphatase (PpBC) and the individual phosphatase domain (PpC) have almost 
overlapping pH dependence curves (Figure 4-11a). These results suggest that PpBC is 
likely to have an independent phosphatase active site that is not sterically hindered by the 
CKS domain, neither statically nor dynamically.  
The turnover rate of the phosphatase activity in the fusion protein is about 30-fold 
lower than that of KdsCEc. A group 2 tail (represented by the α-helical tail in 
Haemophilus influenzae) is present at the C-terminal of this fused KdsC, which locates in 
the C-terminal part of the fusion protein. Therefore, it is possible for the C-terminal tail to 
act as a movable region, as observed in KdsCEc (Chapter 2). The movable tail may insert 
into the active site of another monomer, for example an adjacent monomer in the 
tetrameric KdsCEc, and assist in product release (Chapter 3). Tail-less KdsCs, either 
truncated KdsCEc or natural tail-less KdsCAa, generally have a kcat 102-103 fold lower than 
the full-length KdsCEc. As a tailed KdsC, PpBC (KDO8P) has a catalytic rate between 
other characterized tailed and tail-less KdsCs. On the other hand, the KM value for 
KDO8P of the fusion protein is 30-fold higher than that of KdsCEc. Therefore the 
catalytic efficiency (kcat/ KM) of the phosphatase activity in the fusion protein is 900-fold 
lower than that of KdsCEc. A structural parallel between the KdsC domain of PpBC and 
KdsCEc needs to be drawn to reveal molecular basis for the extraordinary low catalytic 
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efficiency of the former. Whether a tetrameric structure can be formed and whether the 
C-terminal tail can insert into the active site of another monomer may help understanding 
the mechanism of PpBC. 
Though the turnover rate of the phosphatase in the fusion protein is low, the pH 
profile (Table 4-11a) may suggest an advantage of this phosphatase in the fusion protein. 
When comparing the pH dependence of the phosphatase activity of PpBC and PpC to that 
of KdsCEc, an obvious relative activity enhancement in the alkaline pH range can be 
observed for PpC and PpBC. The activity of KdsCEc drops immediately above pH 8, and 
retains only 10% activity at pH 10, which is the optimum pH of KdsBs. However for the 
fusion protein, the phosphatase activity retains 50% activity at pH 10. The optimum pH 
for the overall coupled activity is at pH 10 (Figure 4-11b), limited by the CKS activity. 
Therefore, the expansion of pH adaption to the alkaline range in the PpC domain may 
have enhanced the efficiency of coupling with the PpB domain. 
Enzyme coupling in the fusion – To enable efficient enzyme coupling and avoid 
intermediate accumulation, comparable activities for both enzymes are required. In the 
case of this bifunctional enzyme, the kcat of PpBC (KDO8P) is about 10-fold higher than 
that of PpBC (KDO/CTP), which inevitably leads to production of more KDO than can 
be consumed. However, the advantage is that the lagging phase is shortened by a fast 
build-up of the KDO intermediate. An even larger difference in catalytic rate is observed 
for the KdsCEc (kcat = 456 s-1)and KpsUEc (kcat = 1.35 s-1 [16]) pair, making these two 
enzymes extremely inappropriate to couple at a 1:1 stoichiometric ratio, as occurrs in 
PpBC where one molecule of PpB is covalently linked to one molecule of Ppc. The E. 
coli enzyme pair, unless having 103-fold more KdsCEc than KpsUEc, will produce excess 
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KDO. In this sense, PpBC is much more efficient in unitizing KDO. The activity 
coupling is also facilitated by other similar properties shared between the two activities, 
including a close temperature optimum (Figure 4-12a), the overlapping Mg2+ utilizing 
range (Figure 4-13), and the coincident pH adaption in the alkaline range (Figure 4-11a).  
In PpBC, the phosphatase activity is 2.5 fold higher than the activating activity in 
catalytic efficiency (kcat/KM). In contrast, the individual domains have an inverse trend 
with PpB being 3-fold more active than PpC (Table 4-6). The time course of the PpBC 
reaction and the PpB/PpC mixture reaction (Figure 4-15)shows that the fusion enzyme 
achieves the exhaustion of the reactant faster than the mixture of two individual domains 
when utilizing KDO8P and CTP as substrates, suggesting that PpBC is indeed a better 
enzyme. The spatial proximity of two domains must be a critical factor contributing to 
the efficiency of the fusion protein. 
Overall, the coupling of two activities in this bifunctional enzyme seems not to 
improve the catalytic rate for the formation of final product (monitored by PPi), but the 
apparent catalytic rate of PpBC is higher than that of PpB/PpC mixture. However, other 
advantages of enzyme fusion, for example the sharing of a single regulatory site [49], 
substrate channeling [50], and synergic effects [51, 52], will require additional 
experiments to prove.  
From the standpoint of evolution, possession of two complete set of KDO 
biosynthetic genes in P. putida F1 is possibly caused by gene duplication under 
environmental stress. In particular, the incorporation of a full set of KDO biosynthetic 
genes into the kps gene cluster may enhance the capsular expression in P. putida F1, 
which can live on otherwise toxic aromatic compounds. The occurrence of KDO 
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biosynthetic gene cluster (kpsF, kdsA, kdsC, and kpsU) may be a positive evolutionary 
product that possibly improves the efficiency of the entire pathway by shortening spatial 
distances between enzymes. The first two discovered fusion gene examples that encode 
the bifunctional KdsBC may be an evolutionary error-try intermediate, which is not 
greatly improved in enzyme activities but still needs perfection by nature. As more 
microbial genomes are sequenced, these speculations can be further tested. 
 
4.6 Future Directions 
A crystal structure of PpBC in the presence and/or absence of KDO8P and CTP 
should be obtained. A structural comparison between the bifunctional enzyme and its 
individual parts, PpB and PpC, could possibly reveal details of how KDO moves between 
domains.  
The assay method developed for the bifunctional enzyme can be further applied to 
high throughput screening of the E. coli KdsD, KdsA, KdsC, and KdsB biosynthetic 
pathway. If all these enzymes can be efficiently coupled, a high throughput assay can be 
performed on small molecular libraries to simultaneously screen for inhibitors of the 
entire pathway. 
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Mechanistic insights into 3-deoxy-D-manno-octulosonate 8-phosphate 
phosphatase (KdsC) were studied and presented in this dissertation. The combination of 
X-ray crystallography structural analysis and enzymatic characterization revealed the 
molecular basis of the regulatory mechanism and of substrate specificity of KdsC. A gene 
fusion of kdsC and its consecutive gene in the pathway, kdsB, was identified and 
expressed as a bifunctional enzyme. The characterization of this enzyme kdsBC 
contributed to understanding the activity coupling in the pathway. 
Seven sets of crystal structures for E. coli KdsC and its variants were solved. The 
deletion of the last eight amino acids at the C-terminal end enabled products to be 
captured in the active site. Residues Lys102, Gly77, Thr76, etc. interact with KDO or Pi 
portion in the active site. Tetramerization also plays a critical role in achieving high 
substrate specificity since each active site is partially covered by a cap-like adjacent 
monomer, with the cap monomer residues Arg86, Val56 and Leu90 forming salt bridges 
or hydrophobic interactions with the KDO portion.  Mutagenesis studies may lead to a 
further clarification of the significance of these residues. 
The crystal structures illustrated two major conformational changes in KdsC. One 
conformational change occurs in the C-terminal tail, which undergoes transition between 
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solvent exposed state and active site insertion, and the other occurs in the two loops at the 
active site, which move to form a bulge coincident with the tail insertion or substrate 
binding. A tetrameric structure must be formed to enable the tail insertion into the active 
site of the adjacent monomer. The C-terminal end of the tail occupies the same space as 
the KDO portion, and forms similar specific contacts with the active site residues. The 
presence of the tail is essential for achieving a high catalytic efficiency for KdsC from E. 
coli, because slower turnover rates are observed for both the native tail-less KdsCs and 
the tail deletion mutant of E. coli KdsC. The tail possibly functions as an active facilitator 
of the releasing products by competing with KDO for active site occupancy and 
destabilizing Pi binding in the active site. A catalytic cycle model for the tail was thereby 
proposed. This is a unique mechanism discovered in the Haloacid Dehalogenase 
Superfamily to date. The differences in the tail region lead to the classification of KdsC 
into three groups which are likely related evolutionarily. Characterization of KdsC from 
the different groups will be helpful to understand how the tail evolves to improve the 
function of the enzyme. 
During the database search of KdsC, a fused gene was identified with kdsB gene 
on the N-terminal end and kdsC gene on the C-terminal end. This fusion gene is likely 
involved in the capsular polysaccharide biosynthesis because it resides within the kps 
cluster which encodes capsular synthesis and assembly enzymes. The recombinant 
protein expressed from the fused gene is proven to be a bifunctional enzyme with both 
KDO 8-P phosphatase activity and CMP-KDO synthetase activity. Characterization of 
the bifunctional enzyme reveals several special properties enabling the coupling of the 
two enzymes whose E. coli counterparts are difficult to couple in 1:1 ratio. The KdsB 
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activity is the rate-limiting step in this coupled reaction, and shows similar kinetic 
parameters with other capsular CMP-KDO synthetases. The KdsC activity is much 
slower than the similarly tailed KdsCs from E. coli and H. influenzae, making the fused 
gene KdsC activity only slightly faster than the KdsB activity to avoid over accumulation 
of the intermediate. The pH adaption of the KdsC activity expands to the alkaline range 
to overlap with the optimum pH of KdsB. A combination of Malachite green assay and 
Eikonogen assay allows measurement of Pi and PPi releases in the same reaction mixture, 
therefore opens the possibility of obtaining kinetic information for both steps in the 
coupled reaction, and paves the way for assaying the whole KDO biosynthetic pathway 












ATTEMPTS TO EXPRESS  
S-ADENOSYL-L-METHIONINE HYDROLASE 
 
SAMase Catalyzes SAM Degradation 
S-adenosyl-L-methionine (SAM) is one of the most ubiquitous and important 
naturally-occurring molecules [1]. The ability to donate various moieties to selected 
nucleophiles makes SAM an important substrate in the pharmacological activation and 
deactivation of various biological nucleophiles [2, 3]. Research tools are needed to 
regulate the pool size of SAM in vivo in order to elucidate the mechanism of important 
biological processes such as E. coli’s defense [4, 5]. Though chemical degradation of 
SAM has been studied [6], a biocompatible enzymatic reaction is required for down-
regulating SAM in biological systems. The only known enzymatic degradation reaction 
of SAM is the hydrolysis catalyzed by SAM hydrolase (SAMase, EC 3.3.1.2), a 17 kDa 
protein. SAM is degraded to homoserine (HS) and methylthioladenosine (MTA) in this 
reaction (Figure A-1) [7]. SAMase was used to down-regulate the level of SAM by 
either adding a T3 phage infected E. coli extract[8] or introducing a pBAD plasmid 
containing the SAMase gene [5]. However, both methods cannot quantitatively control 
the pool size of SAM due to the lack of characterization of SAMase. Purified SAMase 










Figure A-1 Enzymatic degradation of SAM. 
 
 
Attempts to Clone Recombinant SAMase 
SAMase is cytotoxic to E. coli host cells due to its unregulated hydrolytic activity 
to degrade SAM, a molecule required for cell survival. Therefore, cloning of SAMase 
gene into unrestricted vectors such as a pT7-7 vector failed. In the pT7-7 vector, the T7 
promotor is driven by T7 RNA polymerase, which is expressed from an IPTG inducible 
gene on the host strain [9]. In the absence of IPTG, the target gene cloned into the pT7-7 
still expresses small amount of protein. The “leak” of SAMase protein from the 
SAMase/pT7-7 plasmid expression resulted in a halt of E. coli host cell growth, therefore 
no protein could be obtained from fermentation. To avoid the leak of SAMase expression 
before IPTG induction, tightly regulated vectors were used. Posnick reported the 
recombination of the SAMase gene into a L-arabinose controlled pBAD plasmid 
(Invitrogen) and observed enzyme activity [5]. However, our group discovered that 
Posnick’s SAMase gene was actually a C75Y mutant, and the mutant enzyme has very 



































More attempts were made to express the full-length SAMase in a tightly regulated 
plasmid-based system in my study. First I utilized the pLEX vector (Invitrogen) which 
has a PL promoter.  A λlc repressor upstream to the PL promoter is subject to restriction 
by tryptophan. Therefore, only in the presence of tryptophan can this promoter be turned 
on. A tryptophan-absent media was used in the cloning experiments, however, only a 
couple of single colonies were obtained after ligation, and all clones sequenced were 
either frame-shifted products or multiple-site mutants. Another tightly regulated vector 
utilized in my study is a double-operator system, pAu21a (Expression Technologies Inc.). 
It has two lacI repressors upstream and another lacI repressor downstream to the 
multiple-cloning site. This design can increase the repression of background leakage 20 
to 70 fold. Yet the cloning efforts resulted in no colonies.  
Finally, an optimized SAMase gene using all E. coli-friendly codons were 
constructed by DNA 2.0 Inc. Still no positive clone was obtained after trials of cloning 
the optimized SAMase gene into any available circular plasmid. All these attempts 
strongly suggest that trace amount of SAMase is fatal to E. coli cells.  
 
Mutant C75Y of SAMase 
The plasmid encoding SAMase C75Y/pBAD was obtained from Posnick [5]. This 
mutant is a potential close representative of SAMase, therefore worth studying when the 
wild-type protein could not be expressed. Attempts were made to transfer the mutant 
gene from pBAD cloning vector into expression vectors such as pT7-7, pT7-LOH (an N-
terminal his-tagged vector based on pT7-7), and pLEX. Only C75Y/pT7-LOH was 
successfully constructed. However, although colonies of XL1-Blue E. coli containing 
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C75Y/pT7-LOH could be amplified in liquid media, the expression cell lines such as 
BL21(DE3) and ER2566 containing the plasmid failed to grow in liquid media. A pLEX 
system compatible E. coli strain, GI724, was able to grow in liquid media after 
transformed with the C75Y/pT7-LOH plasmid. However, no overexpression of the C75Y 
protein was obtained. These results suggest that the C75Y mutant is less cytotoxic than 
the wild-type SAMase, but can only exist in small concentration before destroying the 
host cells.  
 
Intein-mediated Protein Ligation 
Intein-mediated protein ligation (IPL) allows separate expression of two 
sequential SAMase fragments with self-cleavable intein tags. Subsequent ligation of the 
two parts was used to form a full-length protein through a thiol substitution reaction [10, 
11]. This strategy was adopted to avoid expression of the full-length active SAMase in E. 
coli host cells, because of the aforementioned cytotoxicity. The IMPACTTM-TWIN 
system (New England Biolabs) was used to clone, express and purify the two fragments 
of SAMase [12]. SAMase I, the N-terminal fragment of SAMase including residue 1-74, 
was fused with an Mxe GyrA intein and a chitin binding domain (CBD) at its C-terminus. 
After immobilizing the fusion protein onto chitin columns through the interaction 
between its CBD and chitin resins, the Mxe GyrA intein tag can be cleaved under 
treatment of small thiol molecules such as dithiothreitol (DTT) or 2-mercaptoethane 
sulfonic acid (MESNA). The cleavage of intein results in a thioester, a functional group 
required for the subsequential ligation reaction. The second peptide termed SAMase II 
consists of residue 75-152, starting with Cys75. The N-terminal residue of SAMaseII is 
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required to be a Cys, whose thiol side chain can serve as a nucleophile in the subsequent 
thiol substitution ligation reaction. SAMaseII was fused with a CBD and an Ssp DnaB 
intein at its N-terminus. The self-cleavage of the intein tag upon swift pH change from 
8.5 to 7 allows regeneration of the N-terminal Cys. With both SAMase I-thioester and 
SAMase II available, a ligation reaction can be performed by incubating both pieces at 
37°C overnight, and finally results in a native amide bond between the two halves 
(Figure A-2) [13]. 
 
 
Figure A-2 Scheme of intein-mediated ligation reaction. SAMase I has a thiolester 
adduct generated by MESNA assisted cleavage of the Mxe GyrA intein. The thiol group 
on the N-terminal cysteine of SAMase II acts as the nucleophile, and finally results in a 
native peptide bond in between.  
 
The clones of both halves fused with intein were obtained in pTWIN1 vector. The 
SAMase I/Mxe GyrA fusion protein was overexpressed in soluble fractions. Significant 
cleavage of the intein was observed when the cell extract was treated with DTT or 
MESNA (Figure A-3). The detection of small molecule weight peptides was enabled 
using tricine SDS-PAGE [14]. Purification of SAMase I was then carried out on a chitin 
column in a batch manner. The column was quickly flushed with buffer A (20 mM Tris 

















pH 8.5, 500 mM NaCl, 1 mM EDTA) containing 60mM MESNA, and incubated at room 
temperature for 24 h. The 8 kDa SAMase I peptide was eluted using buffer A, and the 
column was finally stripped to detect the fusion precursor consisting of the Mxe GyrA 
intein and CBD. The on-column cleavage efficiency was high, since large amount of 
fusion precursor was obtained. But the yield of SAMase I was low, possibly due to the 
low solubility of the peptide. N-terminal sequencing was performed on the resultant 
SAMase I from chitin column, and the residues identified matched the first amino acids 
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Figure A-3 Cleavage tests of SAMase I/Mxe GyrA/chitin binding domain (CBD). Lane 1: 
molecular weight marker; 2: crude extract incubated with 40 mM DTT for 24 h; 3: crude 
extract; 4-7: crude extract incubated with 40, 60, 80, and 100 mM MESNA for 24 h. 
 
 
SAMase II was cloned into pTWIN1 vector downstream to a CBD and an Ssp 
DnaB intein. The fusion protein was overexpressed as inclusion bodies. Directly treating 
the inclusion body with a pH shift from 8.5 to 7 along with a temperature jump from 4 °C 
to 25 °C did not release any SAMase II, likely due to incorrect folding of the fusion 
protein. In order to achieve correct folding, the insoluble fusion protein was subjected to 
a denature-renature procedure starting from denaturing in 7 M guanidine chloride, and 
followed by stepwise dialysis against 8 M, 6 M, 4 M, and 2 M urea in the presence of the 
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glutathione redox pair at 4°C. The renatured fraction was finally dialyzed into a pH 7 
buffer, but no cleavage of intein was observed. Due to the failure of generating a cys at 
the N-terminus of SAMase II through intein cleavage, the subsequential ligation reaction 
was not performed. 
 
Enzyme Assay 
SAMase was coupled with adenosine deaminase (ADA, EC 3.5.4.4), which turns 
MTA into methylthioinosine. Methylthioinosine has a significant lower extinction 
coefficient than that of MTA at 259 nm. Therefore, a decrease of absorbance at 259 nm 
can be monitored for reaction progression [15]. Before mixed in a reaction, SAMase 
solution as will be specified was treated with DNase I and RNase A, incubated at 37°C 
for 30 min, and ultrafiltered to get rid of any NTPs or dNTPs. The 70 µL reaction mixture 
contained 50 mM Tris pH7, 3.5-7 µM SAM chloride, 225 ng ADA, and 3 µL SAMase 
solution as will be specified. The reaction was incubated at 37 °C for 20 min and 
continuously monitored at 259 nm.   
 
Expression of SAMase through T3 Phage infection 
The only organism carrying a SAMase gene is bacteriophage T3, according to the 
genomic data in the NCBI database to date. The T3 phage expresses SAMase within 
minutes after infecting the E. coli host cells, and digests SAM which provides methyl 
groups for E. coli defensive modifications [16]. Besides the full length SAMase, a 
possible “truncated” SAMase containing 125 amino acids with molecular weight of 14 
kDa could also be expressed from an internal start codon coding for Met28. When 
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bacteriophage T3 is inactivated by ultraviolet radiation, it can no longer destroy the host 
cell, and therefore the recipient cells are able to replicate themselves.[17] The infection of 
E. coli with heavily UV-irradiated phage T3 leads to a 3 to 6 fold accumulation of 
SAMase activity over the non-irradiated phage. However, it was still difficult to obtain 
significant amounts of purified SAMase with this method. 
Small scale phage infection experiments were set up in order to obtain small 
amounts of SAMase to validate the assay. Experiments were performed as described [18]. 
Briefly, phage titer was first calculated by plating phage dilutions and the host cell (E. 
coli ATCC 11303) together on soft LB agar, and counting the number of plaques. The 
mid-log phase host strain was infected with T3 phage at a multiplicity of infection (MOI) 
of 3-5, and harvested after 6-7 min of growth at 37°C. The cells were lysed, and the crude 
extract was precipitated with 30-60% ammonium sulfate. The target protein was found in 
the reconstituted precipitate by SDS-PAGE and the concentration of SAMase was 
estimated to be 0.05 mg/mL. This enzyme solution (3 µL) was subjected to enzyme assay 
and proved to be active.   
 
In vitro synthesis can produce trace amounts of active SAMase 
Another strategy to circumvent the cytotoxic full-length protein expression in 
cells was to synthesize the protein by using cell-free invitro coupled 
transcription/translation. A linear DNA template was first constructed according to 
requirements [19] through three-steps of PCR. The finally resulted 701 bp DNA consists 
of components as following (from 5’ to 3’): a bacteriophage T7 promoter, a prokaryotic 
Shine-Dalgarno ribosomal binding site (RBS), an ATG initiation codon, the SAMase 
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gene, a stop codon, and a T7 termination region.   This DNA template was verified by 
sequencing. 
An in vitro transcription reaction (MAXIscript®, Ambion) was first performed to 
validate the production of mRNA at correct size. The reaction mixture contained 2 µL 
buffer as supplied, 1 µg linear DNA template, 1 mM each NTP, 2 µL enzyme mix as 
supplied, and nuclease-free water as supplied up to 10 µL volume. The reaction was 
incubated at 37 °C for 2 h and loaded on an agarose gel for detection. The agarose gel 
showed a 400 bp band when DNA ladder was used, indicating a ~800 base single-
stranded mRNA production.  
The coupled transcription/translation reaction was then carried out using an 
ExpresswayTM kit from Invitrogen. The reaction mixture contained 20 µL buffer as 
supplied, 20 µL E. coli cell extract as supplied, 1.25 µL 50 mM amino acids mixture, 1 
µL 75 mM Met, 1 µL enzyme mix as supplied, 4 µg linear DNA template, and nuclease-
free water up to 100 µL. The reaction was first incubated at 37°C for 30 min, and added 
with 25 µL feeding solution containing 12.5 µL feeding buffer as supplied, 0.6 µL 50 
mM amino acids mixture, 0.5 µL 75 mM Met, and nuclease-free water. After 2 h 
incubation, counting from the beginning, another 25 µL feeding solution was added. The 
reaction was quenched by frozen at -20 °C after 6 h of total incubation. Microgram 
quantities of SAMase were produced in the form of insoluble protein whereas only small 
fraction of soluble SAmase was obtained (Figure A-4). The putative product of insoluble 
SAMase was cut from the SDS-PAGE gel, and subject to an in-gel protease digestion and 
MS/MS analysis. The resultant mass of peptide fragments was searched against the NCBI 
database, and the sequence hit agreed well with the amino acids sequence of SAMase. 
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Reaction temperatures and DNA template concentrations were altered in the hope to 
achieve better solubility, but none of the conditions resulted in significantly higher yield 




Figure A-4 The in vitro transcription/translation synthesis of SAMase. Various 
concentrations of DNA template were used in the reaction mixture, and both soluble 
fractions and insoluble fractions were tested. The band showing in bold red box was 
subject to in-gel digestion and tandem MS analysis. 
 
 
To refold the insoluble SAMase product of the in vitro synthesis, products from 
three reactions (450 µL total) were combined and treated with 7 M guanidine 
hydrochloride, followed by stepwise dialysis against 8 M, 6 M, 4 M urea with DTT, and 
2 M, 0 M urea with glutathione redox pair. The resultant soluble fraction was 24.7 µg/mL, 
containing SAMase and impurities. This fraction (3 µL) was proved to be positive for 
SAMase activity (Figure A-5). However, when scaling up the refolding procedure with 
1700 µL in vitro reaction mixture, all proteins were precipitated at 2 M urea. 
          0      4     2.67    1      4     2.67    1 
Soluble fraction       Insoluble  
17k 
Various DNA template 
conc. (uL/100uL rxn) 
MS/MS sequencing: SAMase 
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 Enzyme blank (self-degradation)
 Enzyme Ctrl of in vitro product
 In vitro product catalyzed degradation
Refold SAMase IB catalyzed degradation
 
Figure A-5 Time course of the ADA coupled SAMase reaction. Included in the legend, 
from up to down, are 1) self-degradation of SAM in the absence of any enzyme sourse; 2) 
the in vitro transcription/translation reaction mixture without a SAMase template; 3) the 
in vitro reaction mixture catalyzed SAM degradation; 4) the refolded SAMase catalyzed 
SAM degradation.  
 
 
The production of insoluble SAMase from in vitro transcription/translation could 
possibly have resulted from the quick production of proteins, which causes the protein 
products to aggregate before finishing folding. Based on this hypothesis, genes of Phe3 
and Lys5 in SAMase were modified to be less favored codon of E. coli, in order to reduce 
translation rate. However, the change of codon did not result in more soluble SAMase 
production from the in vitro synthesis. 
 
Conclusion and Future Directions 
The cytotoxicity of SAMase makes it difficult to clone SAMase gene into any 
circular plasmid, since trace background expression of the enzyme results in E. coli cell 
death. Other cell strains such as yeast, insect or mammalian cells could be used instead of 
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E. coli, but since SAM is critical to all these organisms, the problem of cytotoxicity still 
exists. In future studies, extremely tight-controlled vectors other than those utilized in this 
study should be used to achieve minimal leak of SAMase expression before induction. 
The cell-free in vitro transcription/translation method produced µg levels of 
soluble SAMase at a high cost of purchasing the kit. The DNA template should be further 
optimized to synthesize soluble SAMase, with a goal of obtaining milligram levels of 
SAMase. The optimized SAMase gene sequence made by DNA 2.0 Inc. can be used as 
the linear DNA template in in vitro synthesis in order to enhance both solubility and yield. 
The most promising method to produce large quantity of soluble SAMase is the 
intein-mediated protein ligation, since each half of SAMase can be overexpressed. The 
soluble and thioester-activated SAMase I was obtained in my study, while SAMase II 
was obtained in an insoluble and uncleavable fusion protein. Other cleavable affinity tags 
that can generate an N-terminal cysteine can be used to express and purify SAMase II. 
Once both halves are prepared in high concentration, a ligation reaction can be performed 
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Bacteria release AHLs as messenger molecules in the environment to 
communicate with other bacteria of the same kind, and thereby regulating cell-population 
density. This process is termed quorum sensing [2]. The AHL molecules are termed 
autoinducer (AI), and enzymes catalyzing the synthesis of AHL are termed autoinducer 
synthetase [2]. Orthologs of AI synthase from various microorganisms have been studied 
and reported to transfer different acyl chain onto the cleaved homoserine from SAM [3-6]. 
Two crystal structures of AI synthetase have been solved revealing the substrate binding 
pocket and a hypothetic channel that could possibly fit the length of the acyl chains and 
therefore determining the specificity for the acyl chains [7, 8]. An AI synthases from 
Agrobacterium tumefaciens (TraI) was cloned and expressed for mechanistic studies. 
 
Expression and Purification of Soluble TraI 
TraI was previously cloned into pT7-7 vector in the lab and was moved into a his-
tagged pT7-LOH vector for convenience of purification. The his-tagged TraI expressed 
as inclusion body after fermentation, which is consistent with a previous report [9]. The 
insoluble TraI failed to refold through a denaturation/renaturation procedure. 
Permutations of IPTG concentration, temperature and duration of growth were used in 
the fermentation to optimize the expressing condition of soluble proteins. Finally, when 
using a rare codon repairing cell line, BL21-CodonPlus® -RIL (Stratagene), and growing 
the cell under 37°C overnight after IPTG induction, soluble TraI was obtained (Figure B-
2).  
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Figure B-2 Expression of TraI under different cell-growth conditions. 1. Cells grew at 
17°C overnight after induction; 2. Cells grew at 37°C overnight after induction. CE = 
crude extract. P = cell pellet. 
 
 
TraI was then purified from the crude extract through two chromatographic steps, 
a HisBind® (Novagen) Ni-NTA column followed by a phenyl superose column, and 
achieved above 90% homogeneity. Pure protein was subject to crystallization condition 
screening but no positive hit was obtained. 
 
Purification of holo-ACP 
One of the substrates of TraI is 3-oxo-octanoyl-ACP. ACPs are small proteins 
(~10 kDa) that serve as acyl donor in many biosynthetic processes. The functional form 
of ACP includes a 4-phosphopantetheine cofactor attached to a conserved serine residue, 
termed holo-ACP.. If an acyl chain is attached to the thiol group on the 4-
phosphopantetheine portion, the protein is termed loaded ACP. It is difficult to express 
recombinant E. coli ACP, because without the 4-phosphopantetheine cofactor, the apo-
ACP is cytotoxic [10]. In this study, a spinach holo-ACP was expressed with 
modifications to the protocol reported by Broadwater and Fox [11]. A co-expression 
vector containing tandem ACP and E. coli holo-ACP synthase (ACPS) genes, pBHF-7A, 
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was generously donated by Fox. Instead of using the special fermenter mentioned in 
Fox’s report that can control pH and oxygen supply of the cell culture and grow cells at 
17°C overnight, the cells were grown in a normal fermenter at 37°C for 4 h after 
induction. Holo-ACP expressed accounted for 90% of the ACP pool, while apo-ACP 
accounted for the other 10%. If the cells were grown in a normal fermenter at 17°C 
overnight, only 50% of the ACP pool was expressed as holo-ACP. The co-expressed 
holo-ACP and ACPS were dissociated by purifying the crude extract on a Mono-Q 
column in the presence of 20% isopropanol. The fractions containing holo-ACP were 
further purified using a HisBind® (Novagen) Ni-NTA column followed by a phenyl 
superose to achieve high homogeneity. The final homogenous fraction was subjected to 
intact mass measurement using MALDI-MS, and two species were detected: 9685 Da 
(10%) coincident with molecular weight of apo-ACP and 10022 Da (90%) coincident 
with molecular weight of holo-ACP. The difference between the two species (337 Da) is 
close to the molecular weight of the 4’-phosphopantetheine group (357.349). 
       
Loading of the Acyl Chain 
ACP can be loaded with the desired acyl chain in several ways: 1) (the in vivo 
way) forming holo-ACP from phosphopentetheinyl transferase (Sfp) catalyzed reaction 
between apo-ACP with CoA, followed by addition of AMP activated acyl chain [12]; 2) 
reacting apo-ACP with acyl-CoA catalyzed by Sfp [13]; 3) loading holo-ACP with acyl 
chains by acyl-ACP synthetase [14]. Involvement of enzymes in the reaction increases 
complexity of purification, and may limit the possibility of adding acyl chains that are not 
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favored by these enzymes. Since acyl-ACP is widely used in many biosynthetic pathways, 
we decided to develop a chemical method for acyl loading onto the holo-ACP. 
The general scheme is to first make a reactive thiol addictive on the acyl chain, 
and then attach the acyl portion to the 4-phosphopentethiene through a thiol substitution 
reaction. The thiol addictive can be generated by attacking a carboxylate or anhydride 
form of the acyl portion with a thiol reagent. This reagent should be not only strong 
enough to nucleophilically attack the carboxylate or anhydride, but also a good leaving 
group when the thiol group on phosphopentethiene of holo-ACP attacks to substitute it. A 
compound reported by Johnson and Kent, (4-carboxylmethyl) thiophenol, may be a good 
candidate [15]. The special 3-oxo-octanoyl group required for TraI can be synthesized as 
described [9], by reacting hexanoyl chloride with Meldrum’s acid, followed by the thiol 
reagent attack to activate the acyl chain. These works are to be followed by organic 
synthesis chemists.  
 
Conclusion and Future Directions 
In this study, soluble TraI and holo-ACP were successfully obtained at high 
homogeneity. With the desired acyl chain synthesized, the holo-ACP can be loaded with 
an acyl group and serves as a substrate in TraI reaction. The other substrate SAM is 
lactonized during the reaction after cleavage between C4 and the sulfur ion. TraI and 
SAM hydrolase (Appendix A) possibly share similar mechanism. Therefore, mechanistic 
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